EurekaMag PDF full texts Chapter 45,281

Saraux, A.; Bendaoud, B.; Guedes, C.; Le Goff, P.; Youinou, P. 1998: Antiphospholipid antibodies and Raynaud's phenomenon in rheumatoid arthritis. Clinical and Experimental Rheumatology 16(3): 351

Zhang, X.; Gai, M.; Xu, W. 1996: Antiphospholipid antibodies and antiphospholipid syndrome and their relation with preqnancy-induced hypertension. Zhonghua Fu Chan Ke Za Zhi 31(8): 506-507

Rai, R.S.; Regan, L.; Clifford, K.; Pickering, W.; Dave, M.; Mackie, I.; McNally, T.; Cohen, H. 1995: Antiphospholipid antibodies and beta 2-glycoprotein-i in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Human Reproduction 10(8): 2001-2005

Forastiero, R.R.; Falcón, C.; Rodrigué, S.; Kordich, L.C.; Carreras, L.O. 1993: Antiphospholipid antibodies and cerebral ischemic infarction in a 6-year-old boy. Sangre 38(2): 147-149

Orefice, G.; Ames, P.R.; Coppola, M.; Campanella, G. 1993: Antiphospholipid antibodies and cerebrovascular disease. Acta Neurologica 15(4): 303-310

Nuss, R.; Hays, T.; Chudgar, U.; Manco-Johnson, M. 1997: Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli. Journal of Pediatric Hematology/Oncology 19(3): 202-207

Dupuis, F.; Petit, A.; Salaun, D.; Davous, N.; Sigal, M. 1996: Antiphospholipid antibodies and deep venous thrombosis in hemorrhagic rectocolitis disclosed by pyoderma gangrenosum. Presse Medicale 25(23): 1084

Formiga, F.; Moga, I.; Canet, R.; Pac, M.; Mitjavila, F.; Pujol, R. 1996: Antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Revista Clinica Espanola 196(11): 734-736

Harrison, C.N.; Machin, S.J. 1997: Antiphospholipid antibodies and essential thrombocythemia. American Journal of Medicine 102(3): 317-318

Harwood, L.; Wilson, B. 2001: Antiphospholipid antibodies and hemodialysis vascular access thrombosis. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 28(3): 346-347

Porter, T.F. 2001: Antiphospholipid antibodies and infertility. Clinical Obstetrics and Gynecology 44(1): 29-35

Tincani, A.; Bozzetti, F.; Tardanico, R.; Cerri, G.; Balestrieri, G.; Lazzari, F.; Morassi, L.; Bergonzini, R.; Cattaneo, R.; Radaeli, E. 1993: Antiphospholipid antibodies and intestinal pathology. Journal of Rheumatology 20(12): 2169-2170

Brancaccio, G.; Di Gioia, C.; Prifti, E.; D'Amati, G.; Michielon, G.; Miraldi, F. 2002: Antiphospholipid antibodies and intracardiac thrombosis. A case report. Journal of Cardiovascular Surgery 43(4): 479-482

Finazzi, G.; Galli, M.; Barbui, T. 1994: Antiphospholipid antibodies and intravascular thrombosis. Giornale Italiano di Cardiologia 24(3): 233-236

Jimenez, M.D.; Guerrero, M.; Marenco, J.L.; Sanchez-Burson, J.; Garcia-Bragado, F. 1996: Antiphospholipid antibodies and movement disorders. Revue du Rhumatisme 63(3): 227-228

Viñets, C.; Montiel, I.; González, M.J.; Antem, M. 1996: Antiphospholipid antibodies and neurological disorders. Types and mechanisms. Revista de Neurologia 24(134): 1224-1228

Christensen, K.; Herskind, A.M.; Junker, P. 1993: Antiphospholipid antibodies and occlusive vascular disease. Ugeskrift for Laeger 155(37): 2896-2900

De Jong, A.; Ziboh, V.; Robbins, D. 2000: Antiphospholipid antibodies and platelets. Current Rheumatology Reports 2(3): 238-245

Costa, M.; Rossi, E. 1999: Antiphospholipid antibodies and pregnancy. Annals of the new York Academy of Sciences 876: 383-386

Christiansen, O.B.; Lauritsen, J.G. 1994: Antiphospholipid antibodies and pregnancy wastage. Human Reproduction 9(7): 1359-1362

Maeshima, E.; Maeshima, S.; Yamada, Y.; Yukawa, S. 1993: Antiphospholipid antibodies and regional cerebral blood flow in systemic lupus erythematosus. Ryumachi 33(2): 125-130

Lee, M.K.; Cheng, H.M.; Ng, S.C.; Menaka, N.; Tan, C.T.; Wang, F. 1993: Antiphospholipid antibodies and stroke in the young--a study of three cases. Medical Journal of Malaysia 48(3): 330-335

Marrakchi, H.; Fazaa, B.; Gorgi, Y.; Jellouli, A.; Mokhtar, I.; Kamoun, M.R. 1995: Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature. La Tunisie Medicale 73(2): 149-152

Nahass, G.T. 1997: Antiphospholipid antibodies and the antiphospholipid antibody syndrome. Journal of the American Academy of Dermatology 36(2 Part 1): 149-168; Quiz: 169-172

Hunt, B.J.; Khamashta, M.A. 2000: Antiphospholipid antibodies and the endothelium. Current Rheumatology Reports 2(3): 252-255

Gleicher, N.; Coulam, C. 1999: Antiphospholipid antibodies and thrombosis. Lancet 354(9172): 72-73

Conti, F.; Priori, R.; Pittoni, V.; Pivetti-Pezzi, P.; Valesini, G. 1999: Antiphospholipid antibodies and thrombosis. Lancet 354(9172): 73

Greaves, M. 1999: Antiphospholipid antibodies and thrombosis. Lancet 354(9183): 1031

Ieko, M. 2000: Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody. Rinsho Byori. Japanese Journal of Clinical Pathology 48(4): 293-300

Santoro, S.A. 1994: Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms. Blood 83(9): 2389-2391

Khamashta, M.A.; Hughes, G.R. 1993: Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus. Journal of the American College of Cardiology 22(4): 1269-1270

Romero Gómez, M.; Suárez García, E.; López Lacomba, D.; Marchante, I.; Grande, L.; Castro Fernandez, M. 2000: Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis. Journal of Clinical Gastroenterology 31(3): 237-240

Bodokh, I.; Lacour, J.P.; Perrin, C.; Ferrari, E.; Jourdan, J.; Ortonne, J.P. 1993: Antiphospholipid antibodies associated with cardiac myxoma simulating collagen vascular disease. Presse Medicale 22(22): 1059

Davis, S.; Kern, H.B.; Asokan, R. 1994: Antiphospholipid antibodies associated with clozapine treatment. American Journal of Hematology 46(2): 166-167

Duarte, J.; Cuenca, C.; Domínguez, D.; Guinea, L. 1993: Antiphospholipid antibodies associated with epilepsy, atypical migraine, and chorea. Medicina Clinica 100(1): 38-39

Coulam, C.B.; Kaider, B.D.; Kaider, A.S.; Janowicz, P.; Roussev, R.G. 1997: Antiphospholipid antibodies associated with implantation failure after IVF/ET. Journal of Assisted Reproduction and Genetics 14(10): 603-608

Carbone, J.; Sarmiento, E.; Segovia, P.; Rodríguez-Mahou, M.; Rodríguez-Molina, J.J.é; Fernández-Cruz, E. 2002: Antiphospholipid antibodies evolving into connective tissue disease: follow-up study of women with recurrent misscarriage. Medicina Clinica 119(18): 681-685

Siqueira Neto, J.I.; Santos, A.C.; Fábio, S.R.; Sakamoto, A.C. 1996: Antiphospholipid antibodies in 66 patients with cerebral infarction between 15 and 40 years old. Arquivos de Neuro-Psiquiatria 54(4): 584-589

Alekberova, Z.S.; Prokaeva, T.B.; Reshetniak, T.M.; Aleksandrova, E.N.; Nasonov, E.L. 2000: Antiphospholipid antibodies in Behcet's disease. Klinicheskaia Meditsina 78(5): 37-38

Asherson, R.A.; Dessein, P.H. 1993: Antiphospholipid antibodies in South Africa blacks with connective tissue diseases--more evidence for an 'aPL-negative coagulopathy'?. South African Medical Journal 83(6): 444

Felici, L.; Santoni, M.; Carloni, I.; Coppa, G.V. 1996: Antiphospholipid antibodies in a child: an unusual presentation without thrombotic events. European Journal of Pediatrics 155(11): 994

Rakocević-Stojanović, V.; Lavrnić, D.; Pavlović, S.; Apostolski, S. 1998: Antiphospholipid antibodies in a female patient with the Sneddon syndrome. Vojnosanitetski Pregled 55(4): 435-438

Mader, R.; Ziporen, L.; Mader, R.; Neumann, L.; Buskila, D. 2002: Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory. Clinical Rheumatology 21(5): 386-390

Merino de Lucas, E.; Priego Valladares, M.; Reus Bañuls, S.; Pérez-Mateo Regadera, M. 1998: Antiphospholipid antibodies in acute infection caused by hepatitis C virus. Medicina Clinica 110(6): 238-239

Koike, T. 2000: Antiphospholipid antibodies in arterial thrombosis. Annals of Medicine 32(Suppl 1): 27-31

Aguilar Franco, C.; Lucía Cuesta, J. 2001: Antiphospholipid antibodies in asymptomatic pediatric patients. Anales Espanoles de Pediatria 54(5): 444-449

Sakai, M.; Shirahata, A.; Akatsuka, J.-i.; Fujisawa, K.; Ohkawa, H.; Konishi, S.; Bessho, F.; Miyazaki, S. 2002: Antiphospholipid antibodies in children with idiopathic thrombocytopenic purpura. Japanese Journal of Clinical Hematology 43(9): 821-827

Braham, A.; Safer, L.; Bdioui, F.; Lejmi, A.; Brahmi, I.; Ben Chabenne, N.; Ben Mimoun, H.; Saffar, H. 2001: Antiphospholipid antibodies in digestive diseases. Presse Medicale 30(38): 1890-1897

Ulcová-Gallová, Z. 1994: Antiphospholipid antibodies in gynecology and obstetrics. Ceska Gynekologie 59(1): 28-34

Nestorowicz, B.; Ostanek, L.; Ronin-Walknowska, E.; Fiedorowicz-Fabrycy, I.; Skoczowska, M.; Czajkowska, E.; Fischer, K. 2000: Antiphospholipid antibodies in high-risk pregnancy. Ginekologia Polska 71(6): 500-508

Llorente, M.R.; Carton, J.A.; Cárcaba, V.; Rodríguez-Pinto, C.; Maradona, J.A.; Asensi, V.; Fernández-Urgellés, M. 1994: Antiphospholipid antibodies in human immunodeficiency virus infection. Medicina Clinica 103(1): 10-13

Mutalova, E.G.; Nasonov, E.L.; Arabidze, G.G. 1998: Antiphospholipid antibodies in hypertension. Terapevticheskii Arkhiv 70(12): 38-39

Martinović, Z.; Perisić, K.; Pejnović, N.; Lukacević, S.; Rabrenović, L.; Petrović, M. 1998: Antiphospholipid antibodies in inflammatory bowel diseases. Vojnosanitetski Pregled 55(2 Suppl): 47-49

Elbeialy, A.; Strassburger-Lorna, K.; Atsumi, T.; Bertolaccini, M.L.; Amengual, O.; Hanafi, M.; Khamashta, M.A.; Hughes, G.R. 2000: Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. Clinical and Experimental Rheumatology 18(4): 492-494

Pérez de Oteyza, C.; López Valero, I.; Romero Barbero, J.L.; Marcos Herrero, E.; Muro García, R. 1994: Antiphospholipid antibodies in megakaryocytic thrombopenias. Anales de Medicina Interna 11(6): 263-267

Asensio Sánchez, V.M.; Delicado del Hoyo, F.; Asensio Sánchez, M. 1998: Antiphospholipid antibodies in ophthalmology. Anales de Medicina Interna 15(11): 616

Hornstein, M.D. 2000: Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertility and Sterility 74(4): 635-636

Guzmán, J.; Cabral, A.R.; Cabiedes, J.; Pita-Ramirez, L.; Alarcón-Segovia, D. 1994: Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia. Autoimmunity 18(1): 51-56

Peterová, V.; Fialová, L.; Mikulíková, L.; Malbohan, I. 1996: Antiphospholipid antibodies in patients with neurologic diseases. Sbornik Lekarsky 97(3): 377-383

Giordano, N.; Senesi, M.; Battisti, E.; Traversi, C.; Mattii, G.; Palumbo, F.; Gennari, C. 1998: Antiphospholipid antibodies in patients with retinal vascular occlusions. Acta Ophthalmologica Scandinavica 76(1): 128-129

Massengill, S.F.; Hedrick, C.; Ayoub, E.M.; Sleasman, J.W.; Kao, K.J. 1997: Antiphospholipid antibodies in pediatric lupus nephritis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 29(3): 355-361

Quintero-Del-Rio, A.I. 2002: Antiphospholipid antibodies in pediatrics. Current Rheumatology Reports 4(5): 387-391

Lynch, A.; Marlar, R.; Murphy, J.; Davila, G.; Santos, M.; Rutledge, J.; Emlen, W. 1994: Antiphospholipid antibodies in predicting adverse pregnancy outcome. a prospective study. Annals of Internal Medicine 120(6): 470-475

Birdsall, M.A.; Pattison, N.S. 1993: Antiphospholipid antibodies in pregnancy: clinical associations. British Journal of Hospital Medicine 50(5): 251-260

Kilpatrick, D.C. 1994: Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. British Journal of Obstetrics and Gynaecology 101(8): 739-740

Cervera, R.; García-Carrasco, M.; Font, J.; Ramos, M.; Reverter, J.C.; Muñoz, F.J.; Miret, C.; Espinosa, G.; Ingelmo, M. 1997: Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clinical and Experimental Rheumatology 15(4): 361-365

Khamashta, M.A.; Hughes, G.R. 1994: Antiphospholipid antibodies in sickle cell disease. American Journal of Hematology 45(2): 193-194

McCarty-Farid, G.A. 1993: Antiphospholipid antibodies in systemic lupus erythematosus and Sjögren's syndrome. Current Opinion in Rheumatology 5(5): 596-603

Magarò, M.; Zoli, A.; Galossi, A.; Caricchio, R.; Mirone, L.; Scuderi, F.; Altomonte, L. 1994: Antiphospholipid antibodies in systemic lupus erythematosus: study of a caseload of 120 patients. Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 9(4): 231-235

Blohorn, A.; Guegan-Massardier, E.; Triquenot, A.; Onnient, Y.; Tron, F.; Borg, J.Y.; Mihout, B. 2002: Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovascular Diseases 13(3): 156-162

Yokoi, K.; Ohkura, T.; Tamura, R. 1998: Antiphospholipid antibodies in the elderly patients with ischemic stroke. Rinsho Shinkeigaku 38(3): 203-207

Taylor, L.M.; Chitwood, R.W.; Dalman, R.L.; Sexton, G.; Goodnight, S.H.; Porter, J.M. 1994: Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study. Annals of Surgery 220(4): 544

Rai, R.; Regan, L. 1997: Antiphospholipid antibodies in women undergoing in-vitro fertilization. Human Reproduction 12(1): 197-198

Marco, P.; Lucas, J.; Alonso, A.; Pérez Vázquez, J.; Fernández, P.; Victoria, C.; García, M.C.; Calatayud, R. 1995: Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy. Sangre 40(5): 389-392

Gharavi, A.E.; Pierangeli, S.S.; Espinola, R.G.; Liu, X.; Colden-Stanfield, M.; Harris, E.Nigel. 2002: Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis and Rheumatism 46(2): 545-552

Chamley, L.W. 1997: Antiphospholipid antibodies or not? the role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss. Journal of Reproductive Immunology 36(1-2): 123-142

Disdier, P.; Weiller, P.J. 1998: Antiphospholipid antibodies syndrome. La Revue du Praticien 48(6): 626-631

Mehndiratta, M.M.; Bhattacharya, A.; Gupta, M.; Khawaja, G.K.; Puri, V. 1999: Antiphospholipid antibodies syndrome in 'Stroke in young'. Neurology India 47(2): 122-126

Urfer, C.; Pichler, W.J.; Helbling, A. 1996: Antiphospholipid antibodies syndrome: follow-up of patients with a high antiphospholipid antibodies titer. Schweizerische Medizinische Wochenschrift 126(49): 2136-2140

Cheng, H.M. 1997: Antiphospholipid antibodies, annexin V, and pregnancy loss. New England Journal of Medicine 337(22): 1630-1631

Hunt, J.E.; Krilis, S.A. 1993: Antiphospholipid antibodies, beta 2-glycoprotein i and thrombosis. Lupus 2(5): 285-287

Rai, R.; Regan, L. 1997: Antiphospholipid antibodies, infertility and recurrent miscarriage. Current Opinion in Obstetrics and Gynecology 9(4): 279-282

Newmark, J.; Newmark, H.L.; Marden, L.A. 2000: Antiphospholipid antibodies, ischemic stroke in young adults, and calcium supplementation: a hypothesis. Military Medicine 165(6): 489-491

Balasch, J.; Font, J. 1996: Antiphospholipid antibodies, low-dose aspirin and pregnancy losses. Human Reproduction 11(5): 1140-1141

Capel, P. 1997: Antiphospholipid antibodies, lupus anticoagulant and thrombosis. Revue Medicale de Bruxelles 18(3): 108-110

Aranguren, A.; Pérez-Salazar, M.; Páramo, J.A.; Zozaya, J.; Rocha, E. 2001: Antiphospholipid antibodies, portal and mesenteric thrombosis and carcinoid tumor: a case report. Thrombosis and Haemostasis 86(5): 1334

Harris, E.N.; Gharavi, A.; Asherson, R.A.; Khamashta, M.A.; Hughes, G.R. 1994: Antiphospholipid antibodies--middle aged but robust. Journal of Rheumatology 21(6): 978-981

Canoso, R.T. 1993: Antiphospholipid antibodies. Basic mechanisms, clinical features, and animal models. Stroke 24(12 Suppl): I124-I125

Diez-Ewald, M. 1993: Antiphospholipid antibodies. Review. Investigacion Clinica 34(3): 143-158

Alarcón-Segovia, D.; Cabral, A.R. 1994: Antiphospholipid antibodies. Where do they come from? Where do they go?. Journal of Rheumatology 21(6): 982-989

Ludia, C.; Domenico, P.; Monia, C.; Emilia, A.; Sandra, F.; Agatina, A.L.; Massimo, M.; Cristina, G.; Piero, D.R.; Ignazio, S.; Rosanna, A.; Franco, G.G. 1998: Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?. Autoimmunity 27(3): 141-148

Hewell, S.W.; Hammer, R.H. 1997: Antiphospholipid antibodies: a threat throughout pregnancy. Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 26(2): 162-168

Singer, H.S.; Krumholz, A.; Giuliano, J.; Kiessling, L.S. 1997: Antiphospholipid antibodies: an epiphenomenon in Tourette syndrome. Movement Disorders: Official Journal of the Movement Disorder Society 12(5): 738-742

Karmochkine, M.; Piette, J.C.; Mazoyer, E.; Wechsler, B.; Chérin, P.; Herson, S.; Godeau, P.; Boffa, M.C. 1995: Antiphospholipid antibodies: cause of thrombosis or an epiphenomenon?. Presse Medicale 24(5): 267-270

Arnoux, D.; Boutière, B.; Sanmarco, M. 2000: Antiphospholipid antibodies: clinical significance and biological diagnosis. Annales de Biologie Clinique 58(5): 557-574

Emlen, W. 1996: Antiphospholipid antibodies: new complexities and new assays. Arthritis and Rheumatism 39(9): 1441-1443

De Groot, P.G.; Oosting, J.D.; Derksen, R.H. 1993: Antiphospholipid antibodies: specificity and pathophysiology. Bailliere's Clinical Haematology 6(3): 691-709

Panagariya, A.; Garg, A.; Sureka, R.K. 2000: Antiphospholipid antibody positive young stroke: an analysis of 12 cases. Journal of Postgraduate Medicine 46(4): 258-261

Coulam, C.B. 2002: Antiphospholipid antibody round table report. American Journal of Reproductive Immunology 48(4): 262-265

Coulam, C.B.; Clark, D.A. 2000: Antiphospholipid antibody status and IVF--debate. Fertility and Sterility 74(4): 848-849

Lash, A.A.; Mertens, D.; Okumus, H. 2001: Antiphospholipid antibody syndrome + pregnancy loss: management in primary care settings. Advance for Nurse Practitioners 9(6): 58-63; Quiz: 64-65

Waldo, R.T. 1994: Antiphospholipid antibody syndrome and aortic occlusion. American Family Physician 50(8): 1647; 1650

Hoy, B.; Göbel, U.; Schneider, W.; Luft, F.C. 2000: Antiphospholipid antibody syndrome and appendicitis. American Journal of Medicine 108(5): 435-436

Djelmis, J.; Radoncić, E.; Ivanisević, M. 2001: Antiphospholipid antibody syndrome and fetal outcome. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 55(3): 123-130

Vaidya, S.; Wang, C.; Gugliuzza, K.; Fish, J.C. 1999: Antiphospholipid antibody syndrome and posttransplant renal thrombosis. Transplantation Proceedings 31(1-2): 230-233

Joseph, R.E.; Radhakrishnan, J.; Appel, G.B. 2001: Antiphospholipid antibody syndrome and renal disease. Current Opinion in Nephrology and Hypertension 10(2): 175-181

Matsuda, J. 1997: Antiphospholipid antibody syndrome and thrombosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 86(6): 941-946

Ravelli, A.; Martini, A.; Burgio, R.G.; Falcini, F.; Taccetti, G. 1994: Antiphospholipid antibody syndrome as a cause of venous thrombosis in childhood. Journal of Pediatrics 124(5 Part 1): 831-832

Zecca, G.; Motti, G.; Manzoni, C.; Lazzaro, A.; Mattiuzzo, G. 1995: Antiphospholipid antibody syndrome as a possible cause of paresis in a child. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 17(5): 451-454

Takahashi, A.; Tamura, A.; Ishikawa, O. 2002: Antiphospholipid antibody syndrome complicated by Grave's disease. Journal of Dermatology 29(12): 776-780

Nakayama, M.; Kumon, K.; Yahagi, N.; Haruna, M.; Watanabe, Y.; Hayashi, H. 1998: Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass. Surgery Today 28(4): 423-426

Satti, S.D.; Bartholomew, J.; Gordon, S.M.; Longworth, D.L.; Adal, K.A. 1999: Antiphospholipid antibody syndrome in a patient with neurosarcoidosis. Vascular Medicine 4(1): 37-39

Aoki, K. 2000: Antiphospholipid antibody syndrome in adverse pregnancy. Rinsho Byori. Japanese Journal of Clinical Pathology 48(4): 323-327

Takanashi, J.; Sugita, K.; Miyazato, S.; Sakao, E.; Miyamoto, H.; Niimi, H. 1995: Antiphospholipid antibody syndrome in childhood strokes. Pediatric Neurology 13(4): 323-326

Bocquet, R.; Blanot, S.; Dautzenberg, M.D.; Pierre-Kahn, A.; Carli, P. 1999: Antiphospholipid antibody syndrome in pediatric neurosurgery: a hemostasis problem. Annales Francaises d'Anesthesie et de Reanimation 18(9): 991-995

Stone, J.H.; Amend, W.J.; Criswell, L.A. 1999: Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 34(6): 1040-1047

Zmonarski, S.; Klinger, M. 1996: Antiphospholipid antibody syndrome in systemic lupus erythematosus. Polski Tygodnik Lekarski 51(19-22): 299-302

Rodríguez González, D.; Hernández Camarena, R.; Velarde Ibarra, R.; Urzúa Orozco, D. 1998: Antiphospholipid antibody syndrome, molar pregnancy and cerebral infarct. A case report. Ginecologia y Obstetricia de Mexico 66: 18-20

Lao, M.; Setty, S.; Foss, C. 2001: Antiphospholipid antibody syndrome. A literature review. Minnesota Medicine 84(4): 42-46

Morassi, P.; Parma, A. 1993: Antiphospholipid antibody syndrome: a case report. Clinical considerations. Minerva Medica 84(6): 355-358

Petri, M. 1997: Antiphospholipid antibody syndrome: an acquired cause of venous and arterial hypercoagulability. Mount Sinai Journal of Medicine new York 64(6): 376-382

Amit, M.; Wysenbeek, A.J. 1997: Antiphospholipid antibody syndrome: clinical spectrum and pathogenesis. Harefuah 133(11): 539-543

Goel, N. 1998: Antiphospholipid antibody syndrome: current concepts. Hospital Practice 33(2): 129-30 133-5 140 Passim

Brenner, Z.R.; Myer, S.A. 2000: Antiphospholipid antibody syndrome: implications for nursing practice. Heart and Lung: the Journal of Critical Care 29(5): 331-339

Obisesan, K.A.; Ogunbiyi, A.O. 2000: Antiphospholipid antibody syndrome: two case reports and review of literature. African Journal of Medicine and Medical Sciences 29(1): 65-70

Ikeda, K.; Ando, S.; Koike, M.; Sekigawa, I.; Iida, N.; Hashimoto, H.; Oshimi, K. 2000: Antiphospholipid antibody-associated hemophagocytic syndrome. Ryumachi 40(1): 21-25

Piette, J.C.; Papo, T.; Amoura, Z.; Boffa, M.C. 1996: Antiphospholipid antibody/cofactors. what are they? Why, when and how to search for them? Is treatment justified?. Annales de Medecine Interne 147(7): 492-497

Geva, E.; Winkler, N.; Amit, A.; Lessing, J.B. 1998: Antiphospholipid autoantibodies and reproduction. Harefuah 134(11): 863-868

Malinowski, A.; Dyński, M.A.; Głowacka, E.; Nowak, M.; Wilczyński, J.R.; Kolasa, D.; Tchórzewski, H.; Szpakowski, M. 2000: Antiphospholipid autoantibodies in women treated for infertility. Ginekologia Polska 71(9): 1011-1016

Nasonov, E.L.; Alekberova, Z.S.; Kalashnikova, L.A.; Reshetniak, T.M.; Aleksandrova, E.N. 1998: Antiphospholipid syndrome (Hughes syndrome): 10 years of study in Russia. Klinicheskaia Meditsina 76(2): 4-11

Mitić, G. 2002: Antiphospholipid syndrome accompanying systemic lupus erythematosus. Medicinski Pregled 55(3-4): 89-96

Piette, J.C.; Papo, T.; Amoura, Z.; Blétry, O.; Marie, L.; Saada, V.; Francès, C.; Godeau, P. 1997: Antiphospholipid syndrome and atrophic polychondritis. La Revue de Medecine Interne 18(2): 172-173

Milanov, I.; Bogdanova, D. 2001: Antiphospholipid syndrome and dystonia-parkinsonism. A case report. Parkinsonism and Related Disorders 7(2): 139-141

Adhiyaman, V.; Meara, R.J.; Bhowmick, B.K. 2002: Antiphospholipid syndrome and dystonia-parkinsonism: need for anticoagulation. Parkinsonism and Related Disorders 8(3): 215; Author Reply 217

Guis-Sabatier, S.; Roudier, J.; Arnoux, D.; Rochwerger, A.; Roux, H.; Mattei, J.P. 2000: Antiphospholipid syndrome and factor V Leiden. Three cases with recurrent venous thrombosis. Joint Bone Spine 67(2): 134-136

Kiyama, S. 1997: Antiphospholipid syndrome and neurosurgery. Anaesthesia 52(6): 612

Milanov, I.G.; Rashkov, R.; Baleva, M.; Georgiev, D. 1998: Antiphospholipid syndrome and parkinsonism. Clinical and Experimental Rheumatology 16(5): 623-624

Rai, R.; Regan, L. 1998: Antiphospholipid syndrome and pregnancy loss. Hospital Medicine 59(8): 637-639

Clervoy, P.; Bonnot, O.; Verrot, D.; Nicand, E.; Devillières, P.; Ameil, O.; Lauwerier, L. 1997: Antiphospholipid syndrome and psychosis. L'Encephale 23(2): 105-107

Kunieda, T. 1996: Antiphospholipid syndrome and pulmonary hypertension. Internal Medicine 35(11): 842-843

Rai, R.S. 2002: Antiphospholipid syndrome and recurrent miscarriage. Journal of Postgraduate Medicine 48(1): 3-4

Vinatier, D.; Dufour, P.; Cosson, M.; Houpeau, J.L. 2001: Antiphospholipid syndrome and recurrent miscarriages. European Journal of Obstetrics Gynecology and Reproductive Biology 96(1): 37-50

Godfrey, T.; Khamashta, M.A.; Hughes, G.R. 2000: Antiphospholipid syndrome and renal artery stenosis. Qjm: Monthly Journal of the Association of Physicians 93(2): 127-129

Kitazawa, K.; Furuta, E.; Sugisaki, T. 2000: Antiphospholipid syndrome and renal diseases: a report of two cases. Nihon Rinsho Men'eki Gakkai Kaishi 23(6): 674-676

Vinatier, D.; Dufour, P.; Hatron, P.Y. 1998: Antiphospholipid syndrome and spontaneous abortions. Contraception Fertilite Sexualite 26(2): 119-128

Andrews, P.A.; Frampton, G.; Cameron, J.S. 1993: Antiphospholipid syndrome and systemic lupus erythematosus. Lancet 342(8877): 988-989

Linhartová, K.; Slechtová, J.; Simon, J. 1999: Antiphospholipid syndrome and vascular disease. Casopis Lekaru Ceskych 138(9): 276-279

Amital, H.; Levi, Y.; Shoenfeld, Y. 1998: Antiphospholipid syndrome and vasculitis--just a coincidence?. Harefuah 134(4): 273-276

Turkowska, M.; Fiedorowicz-Fabrycy, I.; Przepiera-Bedziak, H.; Ostanek, L. 1996: Antiphospholipid syndrome as an interdisciplinary medical problem. Polskie Archiwum Medycyny Wewnetrznej 95(5): 486-492

Korkmaz, C.; Harmanci, E.; Metintaş, I.; Gülbaş, Z. 2001: Antiphospholipid syndrome associated with intestinal amoebiasis. Scandinavian Journal of Infectious Diseases 33(12): 938-940

Sõhngen, D.; Heyll, A.; Meckenstock, G.; Aul, C.; Wolf, H.H.; Schneider, W.; Specker, C.; Withold, W. 1994: Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation. American Journal of Hematology 47(2): 143-144

Viallard, J.F.; Marit, G.; Reiffers, J.; Broustet, A.; Parrens, M. 2000: Antiphospholipid syndrome during chronic myelomonocytic leukemia. American Journal of Hematology 63(1): 60

Amigo, M.C.; Khamashta, M.A.; Hughes, G.R. 1998: Antiphospholipid syndrome in SLE. Bailliere's Clinical Rheumatology 12(3): 477-493

Nasonov, E.L.; Alekberova, E.S.; Kliukvina, N.G.; Aleksandrova, E.N.; Salozhin, K.V.; Le Tonqueze, M.; Youinou, P. 1996: Antiphospholipid syndrome in SLE males. Klinicheskaia Meditsina 74(4): 18-22

Manzanares, J.M.; Conget, I.; Rodríguez-Villar, C.; Tassies, D.; Fernandez-Fernandez, F.; Cervera, R.; Levy, I.; Gomis, R. 1996: Antiphospholipid syndrome in a patient with type i diabetes presenting as retinal artery occlusion. Diabetes Care 19(1): 92-94

Krysova, L.A.; Lesniak, O.M.; Putilova, N.V.; Remizova, I.I. 1999: Antiphospholipid syndrome in females with recurrent fetal losses. Klinicheskaia Meditsina 77(7): 43-46

Granel, B.; Serratrice, J.; Pelletier, J.; Reviron, D.; Disdier, P.; Weiller, P.J. 2002: Antiphospholipid syndrome in husband and wife and multiple sclerosis in the daughter. Presse Medicale 31(1 Part 1): 23

Uszyński, M.ła.; Uszyński, W. 2002: Antiphospholipid syndrome in obstetrics--a new version of criteria, pathomechanism and the prophylaxis. Ginekologia Polska 73(6): 553-566

Shoenfeld, Y.; Sherer, Y.; Blank, M. 1998: Antiphospholipid syndrome in pregnancy--animal models and clinical implications. Scandinavian Journal of Rheumatology. Suppl 107: 33-36

Etherington, J.; Cooper, A.; Buchanan, N. 1994: Antiphospholipid syndrome in rheumatoid arthritis presenting with sensorineural deafness. Lupus 3(1): 63-64

Mitrović, D.; Popović, M.; Stefanović, D.; Cirković, M.; Glisić, B.; Pavlica, L.; Popović, R.; Pejnović, N. 1998: Antiphospholipid syndrome in systemic connective tissue diseases. Vojnosanitetski Pregled 55(2 Suppl): 29-33

Borowska-Lehman, J.; Bakowska, A.; Michowska, M.; Rzepko, R.; Izycka, E.; Chrostowski, L. 1995: Antiphospholipid syndrome in systemic lupus erythematosus--immunomorphological study of the central nervous system; case report. Folia Neuropathologica 33(4): 231-233

Mevorach, D.; Goldberg, Y.; Gomori, J.M.; Rachmilewitz, D. 1996: Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. Journal of Clinical Gastroenterology 22(2): 141-143

Daugas, E.; Nochy, D.; Huong, D.L.T.; Duhaut, P.; Beaufils, H.él.èn.; Caudwell, V.ér.; Bariety, J.; Piette, J.-C.; Hill, G. 2002: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. Journal of the American Society of Nephrology: Jasn 13(1): 42-52

Williams, F.M.; Jurd, K.; Hughes, G.R.; Hunt, B.J. 1998: Antiphospholipid syndrome patients' monocytes are "primed" to express tissue factor. Thrombosis and Haemostasis 80(5): 864-865

Bayraktar, Y.; Tanaci, N.; Egesel, T.; Gököz, A.; Balkanci, F. 2001: Antiphospholipid syndrome presenting as portopulmonary hypertension. Journal of Clinical Gastroenterology 32(4): 359-361

Jain, M.; Jain, S.K.; Arora, A.; Yaduvanshi, A. 1998: Antiphospholipid syndrome presenting as superficial venous thrombosis. Journal of the Association of Physicians of India 46(7): 662

Golubeva, V.V.; Strutsenko, A.A.; Solov'eva, A.I.; Aleksandrova, E.N.; Shvareva, I.S.; Veĭn, A.M. 2000: Antiphospholipid syndrome with choreic manifestations. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(12): 89-92

Sevilla, B.; Roldán, I.; Baello, P.; Mora, V.; Salim, M.; Salvador, A. 2000: Antiphospholipid syndrome with myocardial infarction and aortic valve involvement. Revista Espanola de Cardiologia 53(11): 1534-1536

Desauw, C.; Hachulla, E.; Boumbar, Y.; Bouroz-Joly, J.; Ponard, D.; Arvieux, J.; Dubucquoi, S.; Fauchais, A.L.; Hatron, P.Y.; Devulder, B. 2002: Antiphospholipid syndrome with only antiphosphatidylethanolamine antibodies: report of 20 cases. La Revue de Medecine Interne 23(4): 357-363

Patel, Y.I.; St John, A.; McHugh, N.J. 2000: Antiphospholipid syndrome with proliferative vasculopathy and bowel infarction. Rheumatology 39(1): 108-110

Safley, D.M.; McCullough, P.A. 2002: Antiphospholipid syndrome with renal artery embolism: case report. Reviews in Cardiovascular Medicine 3(4): 196-201

Miret, C.; Cervera, R.; Reverter, J.C.; García-Carrasco, M.; Ramos, M.; Mollà, M.; Font, J.; Ingelmo, M. 1997: Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?. Clinical and Experimental Rheumatology 15(5): 541-544

Tauchmanovà, L.; Rossi, R.; Coppola, A.; Luciano, A.; Del Viscovo, L.; Soriente, L.; De Bellis, A.; Di Minno, G.; Lombardi, G. 1998: Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury?. European Journal of Endocrinology 139(6): 641-645

Sherer, Y.; Shoenfeld, Y. 2001: Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis. Current Atherosclerosis Reports 3(4): 328-333

Kundu, A.K. 1998: Antiphospholipid syndrome--a distinct clinical entity. Journal of the Indian Medical Association 96(1): 23-24; 28

Teeger, J.; Asherson, R.A. 1993: Antiphospholipid syndrome--an unusual presentation. South African Medical Journal 83(9): 696

Fijołek, J.; Wiatr, E.; Tomkowski, W.; Fijałkowska, A.; Wiechecka, A.; Jabłoński, W. 2002: Antiphospholipid syndrome--primary or secondary? Therapeutic problem. Pneumonologia i Alergologia Polska 70(1-2): 87-96

Kaburaki, J. 1999: Antiphospholipid syndrome--specificity of antiphospholipid antibodies and thrombosis. Nihon Rinsho Men'eki Gakkai Kaishi 22(1): 1-12

Clark, D.; Rajendran, Y.; Paydar, S.; Ho, S.; Cox, D.; Ryder, M.; Dollard, J.; Kao, R.T. 2018: Advanced platelet-rich fibrin and freeze-dried bone allograft for ridge preservation: a randomized controlled clinical trial. Journal of Periodontology 89(4): 379-387

Piette, A.M.; Mourad, J.J.; Karmochkine, M.; Didon, D.; Gepner, P.; Graveleau, P.; Grenet, D.; Couderc, L.J.; Chapman, A. 1994: Antiphospholipid syndrome. 20 cases. Presse Medicale 23(13): 607-612

Piette, J.C.; Wechsler, B. 1997: Antiphospholipid syndrome. a better codified treatment. Presse Medicale 26(3): 108-109

Gatenby, P.A. 1993: Antiphospholipid syndrome. a clearer understanding of an old problem. Australian Family Physician 22(12): 2139; 2142-2145

Lê, T.H.; Wechsler, B.; Piette, J.C.; Doumith, R.; Bellin, M.F.; Papo, T.; Frenkiel, N.; Godeau, P. 1993: Antiphospholipid syndrome. a new cause of bilateral hemorrhage of the adrenal glands. 4 cases. Presse Medicale 22(6): 249-254

Von Landenberg, P.; von Landenberg, C.; Schölmerich, J.; Lackner, K.J. 2001: Antiphospholipid syndrome. Pathogenesis, molecular basis and clinical aspects. Medizinische Klinik 96(6): 331-342

Sagot, P.; Fiks-Sigaud, M.; Audrain, M.; Muller, J.Y. 1993: Antiphospholipid syndrome. Proposition for management. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 22(3): 293-299

Storek, J.; Shin, Y.K.; Adcox, M.J.; Newlin, F. 1996: Antiphospholipid syndrome: a case demonstrating diagnostic challenge. American Journal of Hematology 52(3): 235

De Moerloose, P.; Tsakiris, D.A. 1993: Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems. Schweizerische Medizinische Wochenschrift 123(46): 2175-2182

Tsakiris, D.A.; de Moerloose, P. 1993: Antiphospholipid syndrome: a new clinical entity? Part 2: pathophysiological aspects and treatment possibilities. Schweizerische Medizinische Wochenschrift 123(46): 2183-2190

Loredo-Abdalá, A.; Carbajal-Rodriguez, L.; Paredes-Aguilera, R.; Reynés-Manzur, J. 1993: Antiphospholipid syndrome: a new diagnostic option in rheumatology in children. Analysis of 3 clinical cases. Boletin Medico del Hospital Infantil de Mexico 50(4): 265-271

Dong, Y. 1996: Antiphospholipid syndrome: a syndrome with re-recognition. Zhonghua Nei Ke Za Zhi 35(1): 7-8

Roubey, R.A. 2000: Antiphospholipid syndrome: antibodies and antigens. Current Opinion in Hematology 7(5): 316-320

Cervera, R.; Piette, J-Charles.; Font, J.; Khamashta, M.A.; Shoenfeld, Y.; Camps, Mía.Teresa.; Jacobsen, S.; Lakos, G.; Tincani, A.; Kontopoulou-Griva, I.; Galeazzi, M.; Meroni, P.Luigi.; Derksen, R.H.W.M.; de Groot, P.G.; Gromnica-Ihle, E.; Baleva, M.; Mosca, M.; Bombardieri, S.; Houssiau, Fédéric.; Gris, J-Christophe.; Quéré, I.; Hachulla, E.; Vasconcelos, C.; Roch, B.; Fernández-Nebro, A.; Boffa, M-Claire.; Hughes, G.R.V.; Ingelmo, M. 2002: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis and Rheumatism 46(4): 1019-1027

Vlachoyiannopoulos, P.G.; Tsiakou, E.; Chalevelakis, G.; Raptis, S.A.; Moutsopoulos, H.M. 1994: Antiphospholipid syndrome: clinical and therapeutic aspects. Lupus 3(2): 91-96

Harris, E.N.; Peirangeli, S.S.; Gharavi, A.E. 2002: Antiphospholipid syndrome: diagnosis, pathogenesis, and management. Journal of the Medical Association of Georgia 91(1): 31-34

Sherer, Y.; Shoenfeld, Y. 2000: Antiphospholipid syndrome: insights from animal models. Current Opinion in Hematology 7(5): 321-324

Velasco, F.; López-Pedrera, C.; Torres, A.; Cuadrado, M.J.; Dobado-Berrios, P.M. 1997: Antiphospholipid syndrome: possible pathogenic mechanisms of thrombosis. Sangre 42(6): 475-481

Reshetniak, T.M.; Alekberova, Z.S. 1998: Antiphospholipid syndrome: serological markers, diagnostic criteria, clinical manifestations, classification, prognosis. Terapevticheskii Arkhiv 70(12): 74-78

Chapaeva, N.N.; Nepomnyashchikh, G.I.; Aidagulova, S.V.; Bakarev, M.A. 2001: Antiphospholipid syndrome: ultrastructure of microvascular endotheliocytes in musculocutaneous bioptates during systemic lupus erythematosus. Bulletin of Experimental Biology and Medicine 131(2): 176-180

Guérin, V.; Couchouron, A.; Vergnes, C.; Parrens, E.; Vernhes, J.P.; Constans, J.; Boisseau, M. 1997: Antiphospholipid syndromes with anti-human beta 2-glycoprotein I antibodies despite negative reactivity in conventional aPL and LA assays. Thrombosis and Haemostasis 77(5): 1037-1038

Wu, J.; Zhou, Z.; Li, X.; Li, X.; Chen, Y.; Wang, G.; Xu, X.; Wang, Z. 2000: Antiphospholipid thrombosis syndrome and acquired activated protein C resistance. Zhonghua Xue Ye Xue Za Zhi 21(3): 122-124

Bick, R.L. 2001: Antiphospholipid thrombosis syndromes. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 7(4): 241-258

Cuadrado, M.J.; Tinahones, F.; Camps, M.T.; de Ramon, E.; Gómez-Zumaquero, J.M.; Mujic, F.; Khamashta, M.A.; Hughes, G.R. 1998: Antiphospholipid, anti-beta 2-glycoprotein-i and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. Qjm: Monthly Journal of the Association of Physicians 91(9): 619-626

Okun, M.S.; Jummani, R.R.; Carney, P.R. 2000: Antiphospholipid- associated recurrent chorea and ballism in a child with cerebral palsy. Pediatric Neurology 23(1): 62-63

Tanne, D.; Triplett, D.A.; Levine, S.R. 1998: Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more. Stroke 29(9): 1755-1758

Forastiero, R.R.; Martinuzzo, M.E.; Carreras, L.O. 1999: Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction. Sangre 44(3): 223-230

Bick, R.L.; Arun, B.; Frenkel, E.P. 1999: Antiphospholipid-thrombosis syndromes. Haemostasis 29(2-3): 100-110

Yap, C.; Yeoh, S.C.; Viegas, O.A. 1998: Antiphospholipids and pregnancy--a review. Singapore Medical Journal 39(7): 331-334

Gantcheva, M.; Angelova, I. 1999: Antiphospholipids in cutaneous vasculitis. Clinics in Dermatology 17(6): 619-624

Zitouni, M.; Turki, F.; Malouche, N.; Kallel, M.; Laadhar, L.; Jeddi, A.; Matri, L.; Makni, S. 2002: Antiphosphoplipid antibodies and retinal occlusive vasculopathy. Annales de Biologie Clinique 60(3): 287-291

Alvarez Venegas, R.; Castellanos Molina, R.; Martínez Bustos, F.; Cruz Mondragón, C. 1997: Antiphysiological and nutritional factor changes in sorghum (Sorghum bicolor (L.) Moench) seeds during germination. Archivos Latinoamericanos de Nutricion 47(2): 136-140

Kobayashi, I. 1999: Antipituitary antibodies. Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 467-469

De Bellis, A.; Bizzarro, A.; Conte, M.; Perrino, S.; Coronella, C.; Solimeno, S.; Sinisi, A.M.; Stile, L.A.; Pisano, G.; Bellastella, A. 2003: Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. Journal of Clinical Endocrinology and Metabolism 88(2): 650-654

Takao, T.; Nanamiya, W.; Matsumoto, R.; Asaba, K.; Okabayashi, T.; Hashimoto, K. 2001: Antipituitary antibodies in patients with lymphocytic hypophysitis. Hormone Research 55(6): 288-292

Maghnie, M.; Lorini, R.; Severi, F. 1994: Antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency. Clinical Endocrinology 40(6): 809-810

Aso, Y.; Mitsuhashi, M. 1998: Antipituitary autoantibodies: potential markers for autoimmune endocrine disorders. Journal of Laboratory and Clinical Medicine 132(1): 4-5

Sreenivasan, P.; Gaffar, A. 2002: Antiplaque biocides and bacterial resistance: a review. Journal of Clinical Periodontology 29(11): 965-974

Molnar, J.; Petofi, S.; Kurihara, T.; Sakagami, H.; Motohashi, N. 1993: Antiplasmid and carcinogenic molecular orbitals of benz[c]acridine and related compounds. Anticancer Research 13(1): 263-266

Omulokoli, E.; Khan, B.; Chhabra, S.C. 1997: Antiplasmodial activity of four Kenyan medicinal plants. Journal of Ethnopharmacology 56(2): 133-137

Alves, T.M.; Nagem, T.J.; de Carvalho, L.H.; Krettli, A.U.; Zani, C.L. 1997: Antiplasmodial triterpene from Vernonia brasiliana. Planta Medica 63(6): 554-555

Akopov, S.E..; Sarkisian, M.A.. 1995: Antiplatelet Effect of Nifedipine depending on its Action on Red Cell Deformability in Essential Hypertension. American Journal of Therapeutics 2(1): 10-14

Mousa 1999: Antiplatelet Therapies: Recent Advances in the Development of Platelet Glycoprotein IIb/IIIa Antagonists. Current Interventional Cardiology Reports 1(3): 243-252

Watkins, S.P..; de Lemos, J.A.. 2001: Antiplatelet Therapy in AMI: Combining GP IIb/IIIa Inhibition with Reduced-dose Fibrinolytic Therapy. Current Interventional Cardiology Reports 3(3): 235-243

Chłopicki, S.; Koda, M.; Chabielska, E.; Buczko, W.; Gryglewski, R.J. 2000: Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 51(4 Part 1): 715-722

Vucenik, I.; Podczasy, J.J.; Shamsuddin, A.M. 1999: Antiplatelet activity of inositol hexaphosphate (IP6). Anticancer Research 19(5a): 3689-3693

Lecompte, T.; de Maistre, E. 1996: Antiplatelet agents (inhibitors of platelet function) orally administered. Bases for their practical use in coronary artery disease. Archives des Maladies du Coeur et des Vaisseaux 89(11 Suppl): 1507-1513

Jackson, A.; Luisi, A.F. 1999: Antiplatelet agents and the role of clopidogrel in the prevention of secondary atherosclerotic events. Medicine and Health Rhode Island 82(8): 297-299

Lecompte, T. 1999: Antiplatelet agents and their therapeutic use. La Revue du Praticien 49(15): 1627-1633

Knight, M.; Duley, L.; Henderson-Smart, D.J.; King, J.F. 2000: Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database of Systematic Reviews 2000(2): Cd000492

Steckel, L. 1999: Antiplatelet agents in acute coronary syndromes. Safety, patient selection are key concerns. Advance for Nurse Practitioners 7(12): 41-4; quiz 45-6

Steinhubl, S.R. 2000: Antiplatelet agents in cardiology: the choice of therapy. Annals of Thoracic Surgery 70(2 Suppl): S3-S8

Weksler, B.B. 2000: Antiplatelet agents in stroke prevention. combination therapy: present and future. Cerebrovascular Diseases 10 Suppl. 5: 41-48

Samama, C.Marc.; Bastien, O.; Forestier, Fçois.; Denninger, M-Hélène.; Isetta, C.; Juliard, J-Michel.; Lasne, D.; Leys, D.; Mismetti, P. 2002: Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001--summary statement. Canadian Journal of Anaesthesia 49(6): S26-S35

Teng, C.M.; Ko, F.N. 1998: Antiplatelet agents isolated from medicinal plants. Research Communications in Molecular Pathology and Pharmacology 102(3): 211-225

Ishikawa, K. 1998: Antiplatelet agents prevent cardiac events in patients with coronary artery disease. Internal Medicine 37(2): 199-202

Lip, G.Y.; Gibbs, C.R. 2001: Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Cochrane Database of Systematic Reviews 4: Cd003333

Adams, H.P. 2001: Antiplatelet aggregating versus anticoagulant agents in preventing early recurrent stroke among patients with atrial fibrillation. Current Neurology and Neuroscience Reports 1(1): 11-12

Morimitsu, Y.; Hayashi, K.; Nakagawa, Y.; Horio, F.; Uchida, K.; Osawa, T. 2000: Antiplatelet and anticancer isothiocyanates in Japanese domestic horseradish, wasabi. Biofactors 13(1-4): 271-276

Bower, S.; Sandercock, P. 1993: Antiplatelet and anticoagulant therapy. Current Opinion in Neurology and Neurosurgery 6(1): 55-59

Cequier, A.; Sabaté, M.; Esplugas, E. 1996: Antiplatelet and anticoagulant therapy after coronary-artery stenting. New England Journal of Medicine 335(15): 1160-1161

Ten Berg, J.ën.M.; Plokker, H.T.; Verheugt, F.W. 2001: Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention. Current Controlled Trials in Cardiovascular Medicine 2(3): 129-140

Garg, R.K.; Gheorghiade, M.; Jafri, S.M. 1998: Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure. Progress in Cardiovascular Diseases 41(3): 225-236

Kang, W.S.; Ryu, C.K.; Chung, K.H.; Ko, M.W.; Joo, J.C.; Yuk, D.Y.; Yoo, H.S.; Yun, Y.P. 1999: Antiplatelet and antithrombotic activities of NQ301, 2-chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone. Biological and Pharmaceutical Bulletin 22(12): 1284-1287

Ozsoylu, S. 1996: Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura. American Journal of Hematology 51(4): 328

Chung, M.I.; Jou, S.J.; Cheng, T.H.; Lin, C.N.; Ko, F.N.; Teng, C.M. 1994: Antiplatelet constituents of formosan Rubia akane. Journal of Natural Products 57(2): 313-316

Daniel, N.G.; Goulet, J.; Bergeron, M.; Paquin, R.; Landry, P.-E. 2002: Antiplatelet drugs : is there a surgical risk?. Journal 68(11): 683-687

Yamaguchi, T. 1996: Antiplatelet drugs as a preventive measure of stroke--treatment strategies by subtypes of ischemic stroke. Japanese Journal of Clinical Hematology 37(9): 808-812

Crassard, I.; Bousser, M.G. 1999: Antiplatelet drugs for prevention of cerebral ischemic accidents. Revue Neurologique (Paris) 155(8): 531-541

Anonymous 2000: Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention. Prescrire International 9(47): 89-90

Anonymous 2000: Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention. Prescrire International 9(47): 83-85

Anonymous 2000: Antiplatelet drugs in cardiovascular prevention: introduction. Prescrire International 9(47): 81

Anonymous 2000: Antiplatelet drugs in cardiovascular prevention: stroke prevention in patients with thrombogenic heart disease. Prescrire International 9(47): 87-88

Anonymous 2000: Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention. Prescrire International 9(47): 85-87

Anonymous 2000: Antiplatelet drugs in cardiovascular prevention: take adverse effects and costs into account. Prescrire International 9(47): 82-83

Thizon-de-Gaulle, I. 1998: Antiplatelet drugs in secondary prevention after acute myocardial infarction. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 17(12): 993-997

Diener, H.C. 1998: Antiplatelet drugs in secondary prevention of stroke. International Journal of Clinical Practice 52(2): 91-97

Bornstein, N.M. 2001: Antiplatelet drugs: how to select them and possibilities of combined treatment. Cerebrovascular Diseases 11(Suppl 1): 96-99

Mittal, S.R. 2001: Antiplatelet effect of aspirin--need for further research. Journal of the Association of Physicians of India 49: 493

Han, G.; Bannerman, D.; Handa, R.K.; Dillingham, E.O.; Lawrence, W.H.; Gollamudi, R. 1997: Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse. General Pharmacology 28(4): 617-621

Anonymous 2002: Antiplatelet effects of herbal products. Dermatology Nursing 14(3): 207

Chen, K.S.; Ko, F.N.; Teng, C.M.; Wu, Y.C. 1996: Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. Journal of Natural Products 59(5): 531-534

Ballenger, J.; Olin, J.W.; Brass, L.M.; Orland, B.I.; Cannon, E.; Rich, S.J.; Dresdale, A.; Stemple, C.; Moreo, K.; Zusman, R. 2000: Antiplatelet pathways development. Panel discussion. Managed Care 9(5 Suppl): 18-24

Srivastava, K.C. 1993: Antiplatelet principles from a food spice clove (Syzygium aromaticum L) [corrected. Prostaglandins Leukotrienes and Essential Fatty Acids 48(5): 363-372

Adrie, C. 1996: Antiplatelet properties of nitrogen monoxide. Archives des Maladies du Coeur et des Vaisseaux 89(11 Suppl): 1527-1532

Simon, D.I.; Stamler, J.S.; Jaraki, O.; Keaney, J.F.; Osborne, J.A.; Francis, S.A.; Singel, D.J.; Loscalzo, J. 1993: Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 13(6): 791-799

Seagroatt, V.; Bulstrode, C.; Murray, D.W. 1994: Antiplatelet prophylaxis. Combination treatment may cause bleeding. Bmj 308(6929): 651

Sullivan, J.L. 1994: Antiplatelet prophylaxis. Consider the protective effect of blood loss from the gut. Bmj 308(6929): 651-652

Aviles, R.J.; Bhatt, D.L. 2002: Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery disease. Journal of Thrombosis and Thrombolysis 13(3): 177-182

Mousa 1999: Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond. Drug Discovery Today 4(12): 552-561

Konstantopoulos, K.; Mousa, S.A. 2001: Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond. Current Opinion in Investigational Drugs 2(8): 1086-1092

Ohteki, H.; Sakai, M.; Doi, K.; Yoshitomi, S. 1996: Antiplatelet therapy after open heart surgery. Kyobu Geka. Japanese Journal of Thoracic Surgery 49(5): 353-358

Goicoechea, M.; Caramelo, C.; Ochando, A.; Andrea, C.; Garvía, R.; Ortiz, A. 2000: Antiplatelet therapy alters iron requirements in hemodialysis patients. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 36(1): 80-87

Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease. Bmj 324(7342): 917

Kleiman, N.S. 2002: Antiplatelet therapy and coronary interventions: childhood friends or permanent partners?. Journal of Interventional Cardiology 15(1): 41-43

Girolami, B.; Bernardi, E.; Prins, M.H.; ten Cate, J.W.; Prandoni, P.; Simioni, P.; Andreozzi, G.M.; Girolami, A.; Büller, H.R. 2000: Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 19(4): 370-380

Conte, M.S.; Belkin, M.; Donaldson, M.C.; Whittemore, A.D. 1998: Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs. New England Journal of Medicine 338(19): 1387-1388

Hennekens, C.H.; Jonas, M.A.; Buring, J.E. 1993: Antiplatelet therapy and risk of stroke. Annals of Epidemiology 3(5): 568-570

Barragan, P.; Pietri, P.; Villain, P.; Silvestri, M.; Roquebert, P.O. 1996: Antiplatelet therapy during coronary endoprosthesis placement. Archives des Maladies du Coeur et des Vaisseaux 89(11 Suppl): 1515-1520

Underwood, M.J.; More, R.S.; de Bono, D.P.; Gershlick, A.H. 1994: Antiplatelet therapy following coronary artery surgery. Journal of the Royal Society of Medicine 87(2): 63-65

Gershlick, A.H. 1997: Antiplatelet therapy following stent deployment. Heart 78(Suppl 2): 24-26

Ueno, M.; Masuda, H.; Nakamura, K.; Sakata, R. 2001: Antiplatelet therapy for a pregnant woman with a mechanical aortic valve: report of a case. Surgery Today 31(11): 1002-1004

Koudstaal, P.J. 2000: Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2000(2): Cd000186

Collins, R.; Baigent, C.; Sandercock, P.; Peto, R. 1994: Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. Bmj 309(6963): 1215-1217

Jain, D.; Katus, H.A.; Richardt, G. 2001: Antiplatelet therapy in acute coronary syndromes without persistent ST-segment elevation. Cardiovascular Drugs and Therapy 15(5): 423-436

LeBlanc, J.G.; Sett, S.S.; Vince, D.J. 1993: Antiplatelet therapy in children with left-sided mechanical prostheses. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 7(4): 211-215

Tisdale, J.E. 1998: Antiplatelet therapy in coronary artery disease: review and update of efficacy studies. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 55(19 Suppl. 1): S8-16

Matsuda, T. 1998: Antiplatelet therapy in elderly. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 35(10): 703-712

Jafary, F.H.; Kimmelstiel, C.D. 2000: Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents. Journal of Thrombosis and Thrombolysis 9(2): 157-162

Jafary, F.H.; Kimmelstiel, C.D. 2000: Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors. Journal of Thrombosis and Thrombolysis 9(2): 163-174

Humphreys, D.M. 1997: Antiplatelet therapy in ischaemic events. Lancet 349(9069): 1914

Kohriyama, T.; Tanaka, E.; Katayama, S.; Yamamura, Y.; Nakamura, S. 1994: Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters. Rinsho Shinkeigaku 34(8): 771-776

Crawford, K.M.; Talbert, R.L. 2001: Antiplatelet therapy in secondary stroke prevention. Expert Opinion on PharmacoTherapy 2(10): 1609-1613

Calverley, D.C. 2001: Antiplatelet therapy in the elderly. Aspirin, ticlopidine-clopidogrel, and GPIIb/GPIIIa antagonists. Clinics in Geriatric Medicine 17(1): 31-48

Mannucci, P.M.; Cimminiello, C.; Cattaneo, M. 1993: Antiplatelet therapy in the prevention of cardiovascular diseases. Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 8(3): 189-194

Talley, J.D. 1994: Antiplatelet therapy in the treatment of coronary heart disease. Journal of the Arkansas Medical Society 91(5): 241-242

Alvarez-Sabín, J.; Montaner-Villalonga, J. 1999: Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE. Revista de Neurologia 29(8): 780-784

Benavente, O.; Hart, R.G. 1997: Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation. Journal of the Neurological Sciences 153(1): 110; Author Reply 112

MacMahon, S.; Rodgers, A.; Collins, R.; Farrell, B. 1994: Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. Journal of Bone and Joint Surgery. British Volume 76(4): 521-524

Goodnight, S.H.; Coull, B.M.; McAnulty, J.H.; Taylor, L.M. 1993: Antiplatelet therapy--Part i. Western Journal of Medicine 158(4): 385-392

Goodnight, S.H.; Coull, B.M.; McAnulty, J.H.; Taylor, L.M. 1993: Antiplatelet therapy--Part Ii. Western Journal of Medicine 158(5): 506-514

Calverley, D.C.; Roth, G.J. 1998: Antiplatelet therapy. Aspirin, ticlopidine/clopidogrel, and anti-integrin agents. Hematology/Oncology Clinics of North America 12(6): 1231-1249 Vi

Brass, L.M. 2000: Antiplatelet therapy: a neurology perspective. Managed Care 9(5 Suppl): 15-17

Zusman, R.M. 2000: Antiplatelet therapy: a perspective from cardiology. Managed Care 9(5 Suppl): 7-10

Olin, J.W. 2000: Antiplatelet therapy: a vascular medicine perspective. Managed Care 9(5 Suppl): 11-14

Easton, J.D.; Diener, H.C.; Bornstein, N.M.; Einhäupl, K.; Gent, M.; Kaste, M.; Sacco, R.L.; Tijssen, J.G.; van Gijn, J. 1999: Antiplatelet therapy: views from the experts. Neurology 53(7 Suppl 4: S32-S37

Sivenius, J.; Cunha, L.; Diener, H.C.; Forbes, C.; Laakso, M.; Lowenthal, A.; Smets, P.; Riekkinen, P. 1999: Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working Group. Neurology 53(4): 825-829

Yoshitomi, Y.; Kojima, S.; Sugi, T.; Yano, M.; Matsumoto, Y.; Kuramochi, M. 1998: Antiplatelet treatment with cilostazol after stent implantation. Heart 80(4): 393-396

Rajtar, G.; Zółkowska, D.; Kleinrok, Z.; Marona, H. 1999: Antiplatelets activity of some xanthone derivatives. Acta Poloniae Pharmaceutica 56(4): 319-324

Visalli, M.A.; Jacobs, M.R.; Appelbaum, P.C. 1997: Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams. Antimicrobial Agents and ChemoTherapy 41(12): 2786-2789

Pankuch, G.A.; Nagai, K.; Davies, T.A.; Jacobs, M.R.; Appelbaum, P.C. 2002: Antipneumococcal activity of BMS 284756 compared to those of six other agents. Antimicrobial Agents and ChemoTherapy 46(1): 251-254

Pankuch, G.A.; Davies, T.A.; Jacobs, M.R.; Appelbaum, P.C. 2002: Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents. Antimicrobial Agents and ChemoTherapy 46(1): 42-46

Weber, T.; Radermecker, M. 1997: Antipneumococcal vaccination. Revue Medicale de Liege 52(9): 570-572

Castellote, F.J.; Atienza, M.P. 1998: Antipneumococcal vaccine in older than 65 years of age. Atencion Primaria 21(9): 646

Miravitlles, M.; de Gracia, J. 1998: Antipneumococcal vaccine. Old controversies and new indications. Archivos de Bronconeumologia 34(6): 295-299

Miravitlles, M.; de Gracia, J. 1998: Antipneumococcal vaccines. Old controversies and new indications (II). Archivos de Bronconeumologia 34(7): 353-357

Mitchell, A.S. 2002: Antipodean assessment. Activities, actions, and achievements. International Journal of Technology Assessment in Health Care 18(2): 203-212

Robin, V.; Irurzun, A.; Amoros, M.; Boustie, J.; Carrasco, L. 2001: Antipoliovirus flavonoids from Psiadia dentata. Antiviral Chemistry and ChemoTherapy 12(5): 283-291

Lamm, S.H. 1997: Antipolymer antibodies, silicone breast implants, and fibromyalgia. Lancet 349(9059): 1170-1; author reply 1172-3

Everson, M.P.; Blackburn, W.D. 1997: Antipolymer antibodies, silicone breast implants, and fibromyalgia. Lancet 349(9059): 1171; author reply 1172-3

Miklósi, A.; Csányi, V.; Gerlai, R. 1997: Antipredator behavior in paradise fish (Macropodus opercularis) larvae: the role of genetic factors and paternal influence. Behavior Genetics 27(3): 191-200

Kavaliers, M.; Choleris, E. 2001: Antipredator responses and defensive behavior: ecological and ethological approaches for the neurosciences. Neuroscience and Biobehavioral Reviews 25(7-8): 577-586

Zhu, H.; Kinzel, W. 1998: Antipredictable sequences: harder to predict than random sequences. Neural Computation 10(8): 2219-2230

Cohen, J. 1976: Antipregnancy vaccine. Contraception Fertilite Sexualite 4(6): 399-400

Kareva, E.N.; Kamernitskii, A.V.; Levina, I.S.; Kirpichnikova, N.V.; Kulikova, L.E.; Podval'nyuk, V.V. 2001: Antiprogestagen activity of 5H-progesterone metabolites and their analogues, 16alpha,17alpha-cyclohexane-5H-pregnan-3,20-diones. Bulletin of Experimental Biology and Medicine 131(4): 340-341

Morgan, A.; Keeble, S.C.; London, S.N.; Muse, K.N.; Curry, T.E. 1994: Antiprogesterone (RU486) effects on metalloproteinase inhibitor activity in human and rat granulosa cells. Fertility and Sterility 61(5): 949-955

Grow, D.R.; Williams, R.F.; Hsiu, J.G.; Hodgen, G.D. 1996: Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. Journal of Clinical Endocrinology and Metabolism 81(5): 1933-1939

Jang, G.R.; Benet, L.Z. 1997: Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use. Journal of Pharmacokinetics and Biopharmaceutics 25(6): 647-672

Heikinheimo, O. 2000: Antiprogestin to clinical use. Duodecim; Laaketieteellinen Aikakauskirja 116(12): 1261-1262

Michna, H.; Fritzemeier, K.H.; Parczyk, K.; Nishino, Y.; Schneider, M.R. 1996: Antiprogestin-progesterone interactions. Cancer Treatment and Research 83: 191-212

Bellido, C.; Gonzalez, D.; Aguilar, R.; Sánchez-Criado, J.E. 1999: Antiprogestins RU486 and ZK299 suppress basal and LHRH-stimulated FSH and LH secretion at pituitary level in the rat in an oestrous cycle stage-dependent manner. Journal of Endocrinology 163(1): 79-85

Anonymous 1992: Antiprogestogens: from abortion to contraception. Progress in human reproduction research 1992(22): 6-7

Ura, H.; Obara, T.; Nishino, N.; Okamura, K.; Namiki, M. 1993: Antiproliferating effect of HMG-CoA reductase inhibitor on human pancreatic cancer cell. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2247-2249

Jantová, S.; Ruzeková, L.; Stankovský, S.; Spirková, K. 1997: Antiproliferation activity and the mechanism of action of 9-bromo-5-morpholino-tetrazolo[1,5-c]quinazoline--potential anticancer drug. Neoplasma 44(4): 240-246

Posner, G.H..; Lee, J.K.; White, M.. C.; Hutchings, R.H..; Dai, H.; Kachinski, J.L..; Dolan, P.; Kensler, T.W.. 1997: Antiproliferative Hybrid Analogs of the Hormone 1alpha,25-Dihydroxyvitamin D(3): Design, Synthesis, and Preliminary Biological Evaluation. Journal of Organic Chemistry 62(10): 3299-3314

Krott, R.; Lebek, J.; Grisanti, S.; Esser, P.; Heimann, K. 2000: Antiproliferative Wirkung von Genistein auf kultivierte retinale Pigmentepithelzellen vom Schwein. Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 214(4): 296-300

Juranić, Z.; Anastasova, F.; Juranić, I.; Stanojković, T.; Radulović, S.; Vuletić, N. 1999: Antiproliferative action of isatine-beta-thiocarbohydrazone and N-ethylisatine-beta-thiocarbohydrazone on human PBMC and on two neoplastic cell lines. Journal of Experimental and Clinical Cancer Research: Cr 18(3): 317-324

Rozen, F.; Zhang, J.; Pollak, M. 1998: Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. International Journal of Oncology 13(4): 865-869

Ylikomi, T.; Laaksi, I.; Lou, Y.-R.; Martikainen, P.; Miettinen, S.; Pennanen, P.; Purmonen, S.; Syvälä, H.; Vienonen, A.; Tuohimaa, P. 2002: Antiproliferative action of vitamin D. Vitamins and Hormones 64: 357-406

Edwards, B.D.; Slevin, M.A.; Dickson, A.J.; Ager, A.; Ballardie, F.W. 1993: Antiproliferative actions of cyclosporin A on endothelial cells are not exerted through protein kinase C (PkC). Biochemical Society Transactions 21(4): 423S

Oh, Y.; Gucev, Z.; Ng, L.; Müller, H.L.; Rosenfeld, R.G. 1995: Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Progress in Growth Factor Research 6(2-4): 503-512

Burger, A.M.; Kaur, G.; Hollingshead, M.; Fischer, R.T.; Nagashima, K.; Malspeis, L.; Duncan, K.L.; Sausville, E.A. 1997: Antiproliferative activity in vitro and in vivo of the spicamycin analogue KRN5500 with altered glycoprotein expression in vitro. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(3): 455-463

Opolski, A.; Kuduk-Jaworska, J.; Wietrzyk, J.; Wojdat, E.; Waszkiewicz, K.; Romaniewska, A.; Radzikowski, C. 2000: Antiproliferative activity in vitro of new malatoplatinum(ll) complexes. Anti-Cancer Drugs 11(5): 363-368

Opolski, A.; Wietrzyk, J.; Chrobak, A.; Marcinkowska, E.; Wojdat, E.; Kutner, A.; Radzikowski, C. 1999: Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines. Anticancer Research 19(6b): 5217-5222

Campbell, M.J.; Hamilton, B.; Shoemaker, M.; Tagliaferri, M.; Cohen, I.; Tripathy, D. 2002: Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Research 22(6c): 3843-3852

Rylova, S.N.; Kozlov, A.M.; Kogtev, L.S.; Gaenko, G.P.; Dyatlovitskaya, E.V. 1997: Antiproliferative activity of ceramides isolated from normal human ovary and ovarian tumor. Biochemistry. Biokhimiia 62(9): 1053-1056

Stavropoulos, N.E.; Ioachim, E.; Pappa, L.; Hastazeris, K.; Agnantis, N.J. 1999: Antiproliferative activity of interferon gamma in superficial bladder cancer. Anticancer Research 19(5c): 4529-4533

Bolos, C.A.; Papazisis, K.T.; Kortsaris, A.H.; Voyatzi, S.; Zambouli, D.; Kyriakidis, D.A. 2002: Antiproliferative activity of mixed-ligand dien-Cu(II) complexes with thiazole, thiazoline and imidazole derivatives. Journal of Inorganic Biochemistry 88(1): 25-36

Merlin, J.L.; Marchal, S.; Ramacci, C.; Notter, D.; Vigneron, C. 1993: Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43 degrees C hyperthermia in sensitive and multidrug-resistant MCF-7 cells. European Journal of Cancer 29a (16): 2264-2268

Karkabounas, S.; Assimakopoulos, D.; Malamas, M.; Skaltsounis, A.L.; Leonce, S.; Zelovitis, J.; Stefanou, D.; Evangelou, A. 2000: Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats. Anticancer Research 20(6b): 4391-4395

Naidu, K.A.; Tang, J.L.; Naidu, K.A.; Prockop, L.D.; Nicosia, S.V.; Coppola, D. 2001: Antiproliferative and apoptotic effect of ascorbyl stearate in human glioblastoma multiforme cells: modulation of insulin-like growth factor-i receptor (IGF-IR) expression. Journal of Neuro-Oncology 54(1): 15-22

Syng-ai, C.; Basu Baul, T.S.; Chatterjee, A. 2002: Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo. Mutation Research 513(1-2): 49-59

Bukoski, R.D.; Bo, J.; Xue, H.; Bian, K. 1993: Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine). Journal of Pharmacology and Experimental Therapeutics 265(1): 30-35

Kiviharju, T.M.; Lecane, P.S.; Sellers, R.G.; Peehl, D.M. 2002: Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(8): 2666-2674

Chan, W.Y.; Ng, T.B.; Rong, S.H.; Yeung, H.W.; Mok, S.C. 1994: Antiproliferative and teratogenic activities of the bishemisuccinates of 7 alpha-hydroxycholesterol and 7 beta-hydroxycholesterol. General Pharmacology 25(4): 767-772

Silber, S. 2002: Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences. Zeitschrift für Kardiologie 91(6): 443-457

Kinjo, J.; Nagao, S.; Tanaka, T.; Nonaka, G.I.; Okabe, H. 2001: Antiproliferative constituents in the plant 8. Seeds of Rhynchosia volubilis. Biological and Pharmaceutical Bulletin 24(12): 1443-1445

Fornas, O.; Mato, M.E.; Webb, S.M. 2000: Antiproliferative effect and cell cycle modulation by melatonin on GH(3) cells. Hormone Research 53(5): 251-255

Sausville, E.A.; Duncan, K.L.; Senderowicz, A.; Plowman, J.; Randazzo, P.A.; Kahn, R.; Malspeis, L.; Grever, M.R. 1996: Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin a. Cancer Journal from Scientific American 2(1): 52-58

Chen, Y.; Li, S.; Zhang, X.; Fan, L.; Yang, C. 2002: Antiproliferative effect of IH764-3 derived from Salvia miltiorrhiza in cultured rat hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 10(3): 223

Huang, H.C.; Wang, H.R.; Hsieh, L.M. 1994: Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. European Journal of Pharmacology 251(1): 91-93

Wee, W.R.; Parandoosh, Z.; Sakamoto, T.; Caton, M.; Nova, M.; McDonnell, P.J. 1996: Antiproliferative effect of basic fibroblast growth factor-saporin mitotoxin on keratocytes in culture. Korean Journal of Ophthalmology: Kjo 10(1): 1-7

Yu, D.M.; Tokuda, N.; Naito, S.; Yoshikawa, M.; Takahashi, K.; Uozumi, J.; Kumazawa, J. 1998: Antiproliferative effect of calcitriol on human prostatic cancer cell lines: unrelated to the expression of major histocompatibility complex antigens or intercellular adhesion molecule-1 (ICAM-1). International Journal of Urology: Official Journal of the Japanese Urological Association 5(6): 595-600

Topp, M.S.; Papadimitriou, C.A.; Eitelbach, F.; Oelmann, E.; Koehler, B.; Oberberg, D.; Von Marschall, Z.; Reufi, B.; Stein, H.; Thiel, E. 1995: Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism. Leukemia and Lymphoma 19(3-4): 319-328

Larrosa, J.M.; Veloso, A.A.; Leong, F.L.; Refojo, M.F. 1997: Antiproliferative effect of intravitreal alpha-tocopherol and alpha-tocopheryl-acid-succinate in a rabbit model of PVR. Current Eye Research 16(10): 1030-1035

Yu, H.G.; Chung, H. 1997: Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits. Korean Journal of Ophthalmology: Kjo 11(2): 98-105

Cassoni, P.; Sapino, A.; Stella, A.; Bussolati, G. 1998: Antiproliferative effect of oxytocin through specific oxytocin receptors in human neuroblastoma and astrocytoma cell lines. Advances in Experimental Medicine and Biology 449: 245-246

Takahashi, M.; Refojo, M.F.; Nakagawa, M.; Veloso, A.; Leong, F.L. 1997: Antiproliferative effect of retinoic acid in 1% sodium hyaluronate in an animal model of PVR. Current Eye Research 16(7): 703-709

Thapar, K.; Kovacs, K.T.; Stefaneanu, L.; Scheithauer, B.W.; Horvath, E.; Lloyd, R.V.; Li, J.; Laws, E.R. 1997: Antiproliferative effect of the somatostatin analogue octreotide on growth hormone-producing pituitary tumors: results of a multicenter randomized trial. Mayo Clinic Proceedings 72(10): 893-900

Vural, B.; Solakoğlu, S.; Dalçik, H.; Vural, F.; Dalçik, C.; Erk, A.; Yücesoy, I. 2000: Antiproliferative effects and insulin-like growth factor-i expression in Balb-C 3T3 fibroblasts after treatment with somatostatin and gonadotropin-releasing hormone analogs. Acta Histochemica 102(3): 353-363

Bortman, P.; Folgueira, M.A.A.K.; Katayama, M.L.H.; Snitcovsky, I.M.L.; Brentani, M.M. 2002: Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Brazilian Journal of Medical and Biological Research 35(1): 1-9

Corsi, L.; Avallone, R.; Cosenza, F.; Farina, F.; Baraldi, C.; Baraldi, M. 2002: Antiproliferative effects of Ceratonia siliqua L. on mouse hepatocellular carcinoma cell line. Fitoterapia 73(7-8): 674-684

Rath, P.C.; Aggarwal, B.B. 2001: Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 21(7): 523-528

Andrei, G.; Snoeck, R.; Piette, J.; Delvenne, P.; De Clercq, E. 1998: Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncology Research 10(10): 523-531

Pryor, K.; Stricker, P.; Russell, P.; Golovsky, D.; Penny, R. 1995: Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro. Cancer Immunology Immunotherapy: Cii 41(5): 309-316

Pinto, J.T.; Lapsia, S.; Shah, A.; Santiago, H.; Kim, G. 2001: Antiproliferative effects of garlic-derived and other allium related compounds. Advances in Experimental Medicine and Biology 492: 83-106

Dowsett, M.; Dixon, J.M.; Horgan, K.; Salter, J.; Hills, M.; Harvey, E. 2000: Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(6): 2260-2267

Zurbonsen, K.; Michel, A.; Vittet, D.; Bonnet, P.A.; Chevillard, C. 1997: Antiproliferative effects of imidazo[1,2-a]pyrazine derivatives on the Dami cell line. Biochemical Pharmacology 54(3): 365-371

Arbaje, Y.M.; Bittner, G.; Yingling, J.M.; Storer, B.; Schiller, J.H. 1993: Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. Journal of Interferon Research 13(1): 25-32

Yoshizawa, Y.; Kawaii, S.; Urashima, M.; Fukase, T.; Sato, T.; Tanaka, R.; Murofushi, N.; Nishimura, H. 2000: Antiproliferative effects of small fruit juices on several cancer cell lines. Anticancer Research 20(6b): 4285-4289

Kornfehl, J.; Formanek, M.; Temmel, A.; Knerer, B.; Willheim, M. 1996: Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 253(6): 341-344

Truedsson, L.; Geborek, P.; Sturfelt, G. 1993: Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82). Clinical and Experimental Rheumatology 11(2): 179-182

Keay, S.; Zhang, C.O.; Marvel, R.; Chai, T. 2001: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor: sensitive and specific urine markers for interstitial cystitis. Urology 57(6 Suppl 1: 104

Durmaz, R.; Deliorman, S.; Isiksoy, S.; Uyar, R.; Erol, K.; Tel, E. 1999: Antiproliferative properties of the lazaroids U-83836E and U-74389G on glioma cells in vitro. Pathology Oncology Research: Por 5(3): 223-228

Kane, K.F.; Langman, M.J.; Williams, G.R. 1996: Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Research 56(3): 623-632

Herdeg, C.; Oberhoff, M.; Karsch, K.R. 1998: Antiproliferative stent coatings: Taxol and related compounds. Seminars in Interventional Cardiology: Siic 3(3-4): 197-199

Schmidbauer, J.M.; Höh, H.; Jähnig, T.; Daberkow, I. 1996: Antiproliferative therapy with 5-fluorouracil in erbium:YAG laser sclerostomy ab externo. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 93(5): 569-575

Zurbonsen, K.; Michel, A.; Bonnet, P.A.; Mathieu, M.N.; Chevillard, C. 1999: Antiproliferative, differentiating and apoptotic effects elicited by imidazo[1,2-a]pyrazine derivatives. General Pharmacology 32(1): 135-141

Cutolo, M.; Sulli, A.; Craviotto, C.; Felli, L.; Pizzorni, C.; Seriolo, B.; Villaggio, B. 2002: Antiproliferative-antiinflammatory effects of methotrexate and sex hormones on cultured differentiating myeloid monocytic cells (THP-1). Annals of the new York Academy of Sciences 966: 232-237

Hadley, A.; Griffiths, S.; Griffiths, L.; Vicenzino, B. 1999: Antipronation taping and temporary orthoses. Effects on tibial rotation position after exercise. Journal of the American Podiatric Medical Association 89(3): 118-123

Pivnenko, T.N.; Epshteĭn, L.M.; Okladnikova, S.V.; Gazha, A.K.; Besednova, N.N. 1998: Antiprotease and immunostimulating effect of peptide components isolated from cuticle of the chicken stomach. Prikladnaia Biokhimiia i Mikrobiologiia 34(4): 455-459

Ceriana, P.; Innocenti, P. 1998: Antiprotease drugs and cardiopulmonary bypass. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(5): 445-446

Bouvet, E. 1997: Antiproteases in every shape. Annales de Dermatologie et de Venereologie 124(12): 839-840

Cavallini, G.; Frulloni, L. 2003: Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results. Jop: Journal of the Pancreas 4(1): 75-82

Matsuo, Y.; Takagawa, I.; Koshida, H.; Kawabata, T.; Nakamura, M.; Ida, T.; Zhou, L.; Marumo, F. 1995: Antiproteinuric effect of a thromboxane receptor antagonist, S-1452, on rat diabetic nephropathy and murine lupus nephritis. Pharmacology 50(1): 1-8

Praga, M.; Paz Artal, E.; Hernández, E.; Segura, J.; Moreno, M.A.; Morales, J.M.; Rodicio, J.L. 1997: Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(12): 2576-2579

Kurokawa, K.; Abe, K.; Saruta, T.; Arakawa, M.; Kikkawa, R.; Ueda, N.; Onoyama, K.; Tomita, K.; Ogawa, N. 2002: Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis. Journal of the Renin-Angiotensin-Aldosterone System: Jraas 3(3): 167-175

Locatelli, F. 1997: Antiproteinuric effect of losartan in patients with chronic renal diseases. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(10): 2204-2206

Navarro, J.F.; Mora, C. 1999: Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy. Diabetes Care 22(6): 1006-1008

Kuriyama, S.; Tomonari, H.; Tokudome, G.; Horiguchi, M.; Hayashi, H.; Kobayashi, H.; Ishikawa, M.; Hosoya, T. 2002: Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy. Hypertension Research: Official Journal of the Japanese Society of Hypertension 25(6): 849-855

Lufft, V.; Kliem, V.; Hamkens, A.; Bleck, J.S.; Eisenberger, U.; Petersen, R.; Ehlerding, G.; Maschek, H.; Pichlmayr, R.; Brunkhorst, R. 1998: Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage. Clinical Transplantation 12(5): 409-415

Haas, M.; Leko-Mohr, Z.; Erler, C.; Mayer, G. 2002: Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 40(3): 458-463

Lakos, G.; Kiss, E.; Regeczy, N.; Tarjan, P.; Soltesz, P.; Zeher, M.; Bodolay, E.; Szucs, G.; Szakony, S.; Sipka, S.; Szegedi, G. 2000: Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. Journal of Rheumatology 27(4): 924-929

Barcat, D.; Constans, J.; Guérin, V. 1999: Antiprothrombin autoantibodies and portal vein thrombosis without antiphospholipid antibodies. Journal of Rheumatology 26(4): 1007-1008

Thomas, E.; Bologna, C.; Leroux, J.L.; Blotman, F. 1993: Antiprothrombinase antibodies in Horton's disease. Presse Medicale 22(14): 687-688

Cugnon; Vandermeulen 1989: Antiproton and antilambda annihilations on several nucleons. Physical Review. C Nuclear Physics 39(1): 181-191

Riedlberger; Amsler; Doser; Straumann; Truöl; Bailey; Barlag; Gastaldi; Landua; Sabev; Duch; Heel; Kalinowsky; Kayser; Klempt; May; Schreiber; Weidenauer; Ziegler; Dahme; Feld-Dahme; Schaefer; Wodrich; Ahmad; Bizot; Delcourt; Jeanjean; Nguyen; Prevot; Auld; Axen; Erdman; Howard; Howard; White; Comyn; Beer; Marshall; Robertson; Botlo; Laa; Vonach 1989: Antiproton annihilation at rest in nitrogen and deuterium gas. Physical Review. C Nuclear Physics 40(6): 2717-2731

Phatak; Sarma 1987: Antiproton annihilation in light nuclei. Physical Review. C Nuclear Physics 36(2): 864-866

Jahns; Stöcker; Greiner; Sorge 1992: Antiproton production and annihilation in nuclear collisions at 15A GeV. Physical Review Letters 68(19): 2895-2897

Kahana; Pang; Schlagel; Dover 1993: Antiproton production from heavy ion collisions at 14.6 GeV/c. Physical Review. C Nuclear Physics 47(4): R1356-R1359

Li; Ko 1994: Antiproton production in Ni+Ni collisions at 1.85 GeV/nucleon. Physical Review. C Nuclear Physics 50(3): 1725-1728

Abbott; Akiba; Beavis; Bloomer; Bond; Chen; Chu; Cole; Costales; Crawford; Cumming; Debbe; Engelage; Fung; Gushue; Hamagaki; Hansen; Hayano; Hayashi; Homma; Huang; Ikeda; Juricic; Kang; Katcoff; Kaufman; Kimura; Kitamura; Kurita; Ledoux; Le Vine MJ; Miake; Morse; Moskowitz; Nagamiya; Olness; Parsons; Remsberg; Roehrich; Sakurai; Sarabura; Stankus; Steadman; Stephans; Sugitate; Tannenbaum; Van Dijk JH; Videbæk; Vient; Vincent; Vutsadakis; Wegner; Woodruff; Wu; Zajc 1993: Antiproton production in p+A collisions at 14.6 GeV/c. Physical Review. C Nuclear Physics 47(4): R1351-R1355

Barrette; Bellwied; Braun-Munzinger; Cleland; Cormier; Dadusc; David; Dee; Diebold; Dietzsch; Duek; Fatyga; Fox; Greene; Germani; Hall; Hemmick; Herrmann; Hogue; Hong; Jayananda; Kraus; Kumar; Lacasse; Lissauer; Llope; Ludlam; Majka; Makowiecki; Mark; Mitchell; Muthuswamy; O'Brien; Pruneau; Rotondo; Sandweiss; da Silva NC; Simon-Gillo; Slaughter; Sonnadara; Stachel; Takai; Takagui; Throwe; Waters; Winter; Wolf; Wolfe; Woody; Xu; Zhang; Zhang; Zou 1993: Antiproton production in relativistic Si-nucleus collisions. Physical Review Letters 70(12): 1763-1766

Agnello; Belli; Bendiscioli; Bertin; Botta; Bressani; Bruschi; Bussa; Busso; Calvo; Cereda; Cerello; Cicalò; Corradini; Costa; De Castro S; Donzella; Feliciello; Ferrero; Filippi; Filippini; Fontana; Galli; Garfagnini; Giacobbe; Gianotti; Grasso; Guaraldo; Iazzi; Lanaro; Lodi Rizzini E; Lucherini; Marcello; Marconi; Masoni; Minetti; Montagna; Morando; Nichitiu; Panzieri; Pauli; Piccinini; Puddu; Rossetto; Rotondi; Rozhdestvensky; Saino; Salvini; Santi; Sapozhnikov; Semprini Cesari N; Serci; Spighi; Temnikov; Tessaro; Tosello; Tretyak; Usai; Vecchi; Venturelli; Villa; Vitale; Zenoni; Zoccoli 1995: Antiproton slowing down inH2 and he and evidence of nuclear stopping power. Physical Review Letters 74(3): 371-374

Møller, S.P.; Csete, A.; Ichioka, T.; Knudsen, H.; Uggerhøj, U.I.; Andersen, H.H. 2002: Antiproton stopping at low energies: confirmation of velocity-proportional stopping power. Physical Review Letters 88(19): 193201

Adamo; Agnello; Balestra; Belli; Bendiscioli; Bertin; Boccaccio; Bonazzola; Bressani; Bruschi; Bussa; Busso; Calvo; Capponi; Cicalò; Corradini; Costa; D'Antone; De Castro S; D'Isep; Donzella; Falomkin; Fava; Feliciello; Ferrero; Filippini; Galli; Garfagnini; Gastaldi; Gianotti; Grasso; Guaraldo; Iazzi; Lanaro; Lodi Rizzini E; Lombardi; Lucherini; Maggiora; Marcello; Marconi; Maron; Masoni; Massa; Minetti; Morando; Montagna; Nichitiu; Panzieri; Pauli; Piccinini; Piragino; Poli; Pontecorvo; Puddu; Ricci; Rossetto; Rotondi; Rozhdestvensky; Salvini; Santi; Sapozhnikov; Semprini Cesari N; Serci; Temnikov 1993: Antiproton stopping power in hydrogen below 120 keV and the Barkas effect. Physical Review. A Atomic Molecular and Optical Physics 47(5): 4517-4520

Cahill; Anderson; Riley 1990: Antiproton storage materials: Response of neon, argon, and benzene to a negative particle. Physical Review. A Atomic Molecular and Optical Physics 41(5): 2315-2321

Ma; Strottman 1991: Antiproton-induced elastic and inelastic scattering at intermediate energies. Physical Review. C Nuclear Physics 44(2): 615-618

Zhang; Liu; Robson; Li 1996: Antiproton-nucleus elastic and inelastic scattering at intermediate energies. Physical Review. C Nuclear Physics 54(1): 332-337

Chiba; Fujitani; Iwahori; Kawaguti; Kobayashi; Kurokawa; Nagashima; Omori; Sugimoto; Takasaki; Takeutchi; Yamaguchi; Yoshida 1988: Antiproton-proton annihilation at rest into pi 0M and gamma M with M= phi, eta ', omega, rho 0, eta, and pi 0. Physical Review. D Particles and Fields 38(7): 2021-2031

Timmermans; Rijken; de Swart JJ 1994: Antiproton-proton partial-wave analysis below 925 MeV/c. Physical Review. C Nuclear Physics 50(1): 48-73

Wycech; Skalski; Smolanczuk; Dobaczewski; Rook 1996: Antiprotonic studies of nuclear neutron halos. Physical Review. C Nuclear Physics 54(4): 1832-1842

Daly, B.M.; Shuster, S. 2000: Antipruritic action of thalidomide. Acta Dermato-Venereologica 80(1): 24-25

Kim, D.H.; Ahn, B.O.; Kim, S.H.; Kim, W.B. 1999: Antipruritic effect of DA-5018, a capsaicin derivative, in mice. Archives of Pharmacal Research 22(6): 549-553

Weisshaar, E.; Heyer, G.; Forster, C.; Hornstein, O.P.; Handwerker, H.O. 1996: Antipruritic effect of antihistaminic and local anesthetic topical agents after iontophoretic histamine stimulation. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 47(5): 355-360

Henry, R.L. 1999: Antipseudomonal antibiotics and cystic fibrosis. Australian and New Zealand Journal of Medicine 29(1): 5-7

Müller, K.; Leukel, P.; Ziereis, K.; Gawlik, I. 1994: Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition. Journal of Medicinal Chemistry 37(11): 1660-1669

Skaria, A.M.; Schmid, U. 1996: Antipsoriatic effect of fumaric acid derivates. Journal of the American Academy of Dermatology 34(2 Part 1): 323-324

Jørgensen, H.A. 1998: Antipsychotic agents and adverse effects. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(28): 4337

Jankūnas, R.; Sveikata, A.; Milasius, A. 2002: Antipsychotic agents and pharmacotherapy of psychoses. Medicina 38(4): 471-477; Quiz 478

Huttunen, M.O. 2002: Antipsychotic agents and the heart. Duodecim; Laaketieteellinen Aikakauskirja 118(15): 1579

Raaska, K. 2002: Antipsychotic agents and weight gain. Duodecim; Laaketieteellinen Aikakauskirja 118(2): 157-162

Wils, V. 1994: Antipsychotic agents in patients with dementia. Tijdschrift Voor Gerontologie en Geriatrie 25(1): 37-38

Arsland, D.; Engedal, K. 1999: Antipsychotic agents--not to patients with dementia?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(2): 263-264

Dilsaver, S.C. 1993: Antipsychotic agents: a review. American Family Physician 47(1): 199-204

Maina, G.; Albert, U.; Ziero, S.; Bogetto, F. 2003: Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?. International Clinical Psychopharmacology 18(1): 23-28

Markowitz, J.S.; Morton, W.A.; Gaulin, B.D. 1997: Antipsychotic blood concentrations: nonstandardization of reference ranges. Journal of Clinical Psychopharmacology 17(2): 121-124

Anonymous 1997: Antipsychotic choices now include quetiapine. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 54(22): 2547

Wooltorton, E. 2002: Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity. Cmaj: Canadian Medical Association Journal 166(9): 1185-1186

Remington, G.; Shammi, C.M.; Sethna, R.; Lawrence, R. 2001: Antipsychotic dosing patterns for schizophrenia in three treatment settings. Psychiatric Services 52(1): 96-98

Larsen, J.S.; Jackson, S.K. 1996: Antileukotriene therapy for asthma. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 53(23): 2821-2830; Quiz: 2877-2878

Galletly, C.A.; Tsourtos, G. 1997: Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 9(2): 77-80

Williams, J.H.; Wellman, N.A.; Geaney, D.P.; Cowen, P.J.; Feldon, J.; Rawlins, J.N. 1996: Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people. Biological Psychiatry 40(11): 1135-1143

Johnson, R.E.; McFarland, B.H. 1993: Antipsychotic drug exposure in a health maintenance organization. Medical Care 31(5): 432-444

Pickford, M. 2000: Antipsychotic drug overdose. Emergency Nurse: the Journal of the Rcn Accident and Emergency Nursing Association 7(9): 17-22

Gerbino, A.; Ward, S.A.; Whipp, B.J. 1996: Effects of prior exercise on pulmonary gas-exchange kinetics during high-intensity exercise in humans. Journal of Applied Physiology 80(1): 99-107

Bennett, J. 1999: Antipsychotic drug treatment. Nursing Standard: 1987) 13(24): 49-53 55-6

Reynolds, G.P. 2001: Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspective. Expert Opinion on PharmacoTherapy 2(4): 543-548

McCombs, J.S.; Nichol, M.B.; Johnstone, B.M.; Stimmel, G.L.; Shi, J.; Smith, R. 2000: Antipsychotic drug use patterns and the cost of treating schizophrenia. Psychiatric Services 51(4): 525-527

Gray, R.; Brown, C.; Hooghamer, R.; Lee, A.; Oxborrow, S. 1996: Antipsychotic drug-induced dysphoria. British Journal of Psychiatry: the Journal of Mental Science 168(5): 655-656

Molitch, M.E. 2000: Antipsychotic drug-induced hyperprolactinemia: clinical implications. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 6(6): 479-481

Armstrong, M.; Daly, A.K.; Blennerhassett, R.; Ferrier, N.; Idle, J.R. 1997: Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype. British Journal of Psychiatry: the Journal of Mental Science 170: 23-26

Gury, C.; Canceil, O.; Iaria, P. 2000: Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia. L'Encephale 26(6): 62-72

Reed, G.A.; Hoffman, W.E. 1982: Antipsychotic drugs and involuntarily committed patients. Hospital Medical Staff 11(5): 16-21

Baptista, T.; Lacruz, A.; Meza, T.; Contreras, Q.; Delgado, C.; Mejìas, M.A.; Hernàndez, L. 2001: Antipsychotic drugs and obesity: is prolactin involved?. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 46(9): 829-834

Tavcar, R.; Dernovsek, M.Z. 2000: Antipsychotic drugs and risk of homicide. Lancet 355(9220): 2073

Knudson, J.F.; Kortepeter, C.; Dubitsky, G.M.; Ahmad, S.R.; Chen, M. 2000: Antipsychotic drugs and venous thromboembolism. Lancet 356(9225): 252-253

Tipper, R.; Hare, E.; Kondracki, S.; Taikato, M.; Lawrie, S.M. 2001: Antipsychotic drugs and venous thromboembolism. Lancet 357(9253): 391; Author Reply 391-2

Melkersson, K.; Hulting, A.L. 2001: Antipsychotic drugs can affect hormone balance. Weight gain, blood lipid disturbances and diabetes are important. Lakartidningen 98(48): 5462

El-Khayat, R.; Baldwin, D.S. 1998: Antipsychotic drugs for non-psychotic patients: assessment of the benefit/risk ratio in generalized anxiety disorder. Journal of Psychopharmacology 12(4): 323-329

Zhang-Wong, J.H.; Seeman, M.V. 2002: Antipsychotic drugs, menstrual regularity and osteoporosis risk. Archives of Women's Mental Health 5(3): 93-98

Bollini, P.; Pampallona, S.; Orza, M.J.; Adams, M.E.; Chalmers, T.C. 1994: Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials. Psychological Medicine 24(2): 307-316

Anonymous 2002: Antipsychotic drugs: the pros and cons. Harvard Mental Health Letter 19(3): 5

Anonymous 2000: Antipsychotic drugs: the weight problem. Harvard Mental Health Letter 17(6): 6-8

Delini-Stula, A.; Berdah-Tordjman, D. 1996: Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia--a study group report. Journal of Psychiatric Research 30(4): 239-250

Haddad, P.M.; Hellewell, J.S.; Wieck, A. 2001: Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports. Journal of Psychopharmacology 15(4): 293-295

Thomassen, R.; Vandenbroucke, J.P.; Rosendaal, F.R. 2001: Antipsychotic medication and venous thrombosis. British Journal of Psychiatry: the Journal of Mental Science 179: 63-66

Patton, S.W.; Misri, S.; Corral, M.R.; Perry, K.F.; Kuan, A.J. 2002: Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 47(10): 959-965

Duggan, L.; Brylewski, J. 2000: Antipsychotic medication for those with both schizophrenia and learning disability. Cochrane Database of Systematic Reviews 2: Cd000030

Pilowsky, L.S.; Costa, D.C.; Ell, P.J.; Murray, R.M.; Verhoeff, N.P.; Kerwin, R.W. 1993: Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123i IBZM SPET (single photon emission tomography) study. Psychological Medicine 23(3): 791-797

Kato, M.M.; Goodnick, P.J. 2001: Antipsychotic medication: effects on regulation of glucose and lipids. Expert Opinion on PharmacoTherapy 2(10): 1571-1582

Berg, M.J. 1998: Antipsychotic medications and ethnicity. Journal of Gender-Specific Medicine: Jgsm: the Official Journal of the Partnership for Women's Health at Columbia 1(2): 16-17

Currier, G.W.; Simpson, G.M. 1998: Antipsychotic medications and fertility. Psychiatric Services 49(2): 175-176

Harrison, M.O.; Krishnan, K.R. 2002: Antipsychotic medications and sudden cardiac death. Psychopharmacology Bulletin 36(3): 91-99

Gracious, B.L.; Findling, R.L. 2001: Antipsychotic medications for children and adolescents. Pediatric Annals 30(3): 138-145

McIntyre, R.S.; McCann, S.M.; Kennedy, S.H. 2001: Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 46(3): 273-281

Snaith, R.P. 1999: Antipsychotic polypharmacy and early death. British Journal of Psychiatry: the Journal of Mental Science 174: 368-369

Stahl, S.M. 1999: Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?. Journal of Clinical Psychiatry 60(7): 425-426

Stahl, S.M. 1999: Antipsychotic polypharmacy, part 2: tips on use and misuse. Journal of Clinical Psychiatry 60(8): 506-507

Procyshyn, R.M.; Kennedy, N.B.; Tse, G.; Thompson, B. 2001: Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 46(4): 334-339

Baillargeon, J.; Contreras, S.A. 2001: Antipsychotic prescribing patterns in the Texas prison system. Journal of the American Academy of Psychiatry and the Law 29(1): 48-53

Weissman, E.M. 2002: Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region. Schizophrenia Bulletin 28(1): 31-42

Takamori, K.; Funakoshi, T.; Hirota, S.; Chaki, S.; Kameo, K. 2002: Antipsychotic profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats. Life Sciences 71(8): 947-952

Rey, J.é A. 2002: Antipsychotic therapy: a pharmacoeconomic perspective. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 59(22 Suppl 8: S5-S9

Sable, J.A.; Jeste, D.V. 2002: Antipsychotic treatment for late-life schizophrenia. Current Psychiatry Reports 4(4): 299-306

García López, M.M. 2001: Antipsychotic treatment in childhood and adolescence: a bibliographical review. Actas Espanolas de Psiquiatria 29(1): 41-46

Devanand, D.P. 1996: Antipsychotic treatment in outpatients with dementia. International Psychogeriatrics 8(Suppl 3): 355-361; Discussion: 381-382

Edell, W.S.; Tunis, S.L. 2001: Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 9(3): 289-297

Daniel, D.G. 2000: Antipsychotic treatment of psychosis and agitation in the elderly. Journal of Clinical Psychiatry 61(Suppl 14): 49-52

Caligiuri, M.R.; Jeste, D.V.; Lacro, J.P. 2000: Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs and Aging 17(5): 363-384

Compton, M.T.; Miller, A.H. 2002: Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacology Bulletin 36(1): 143-164

White, C.M. 2002: Antipsychotics and QTc interval prolongation. Connecticut Medicine 66(8): 461-463

Tényi, T.; Csábi, G.; Trixler, M. 2000: Antipsychotics and breast-feeding: a review of the literature. Paediatric Drugs 2(1): 23-28

Winans, E.A. 2001: Antipsychotics and breastfeeding. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 17(4): 344-347

Curtin, F.; Blum, M. 2002: Antipsychotics and risk of venous thrombosis. British Journal of Psychiatry: the Journal of Mental Science 180: 85

Ray, W.A.; Meador, K.G. 2002: Antipsychotics and sudden death: is thioridazine the only bad actor?. British Journal of Psychiatry: the Journal of Mental Science 180: 483-484

White, A. 2001: Antipsychotics and the law. Australian and New Zealand Journal of Psychiatry 35(4): 541-542

Curran, S.; Harris, L.; Macdonald, A.; Pollock, C.; Roney, G.; Silkstone, D. 2002: Antipsychotics in clinical practice: guidelines for safe and effective use. Human Psychopharmacology 17(2): 75-82

Ochoa Mangado, E. 2001: Antipsychotics use in drug abuse. Actas Espanolas de Psiquiatria 29(3): 172-185

Witchel, H.J.; Hancox, J.C.; Nutt, D.J.; Wilson, S. 2003: Antipsychotics, HERG and sudden death. British Journal of Psychiatry: the Journal of Mental Science 182: 171-172

Barstad, S. 1993: Antipsychotics: high dosages cause side effects. Journalen Sykepleien 81(16): 17-18

Goodnick, P.J.; Rodriguez, L.; Santana, O. 2002: Antipsychotics: impact on prolactin levels. Expert Opinion on PharmacoTherapy 3(10): 1381-1391

Barstad, S. 1993: Antipsychotics: the good ones disappear. Journalen Sykepleien 81(16): 16-17

Bayoumeu, F.; Vial, F.; Zaccabri, A.; Agullès, O.; Laxenaire, M.C. 2002: Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation. Annales Francaises d'Anesthesie et de Reanimation 21(1): 27-31

Bock, M.; Roth, J.; Kluger, M.J.; Zeisberger, E. 1994: Antipyresis caused by stimulation of vasopressinergic neurons and intraseptal or systemic infusions of gamma-MSH. American Journal of Physiology 266(2 Part 2): R614-R621

Wang, H.D.; Wang, Y.P.; Li, C.J.; Lu, D.X.; Yan, L.; Qi, R.B. 1999: Antipyretic action of dexamethasone on egtazic acid-induced fever in rabbits. Sheng Li Xue Bao: 51(2): 161-167

Asha, V.V.; Pushpangadan, P. 1999: Antipyretic activity of Cardiospermum halicacabum. Indian Journal of Experimental Biology 37(4): 411-414

Sokolík, J.; Tumová, I.; Blahová, M.; Dériková, J.; Svajlenová, O.; Svec, P. 1996: Antipyretic activity of carboxylatocopper(II) complexes with salicylate skeleton. Die Pharmazie 51(8): 610-611

Huang, L.; Liu, J.F.; Liu, L.X.; Li, D.F.; Zhang, Y.; Nui, H.Z.; Song, H.Y.; Zhang, C.Y. 1993: Antipyretic and anti-inflammatory effects of Artemisia annua L. Zhongguo Zhong Yao Za Zhi 18(1): 44-48; 63-64

Kurosawa, M.; Sunaga, Y.; Tanaka, T. 1996: Antipyretic effect of Lumbricus spencer in acetylsalicylic acid-induced asthma. Arzneimittel-Forschung 46(2): 172-174

Berbotto, G.A.; Asef, S.G.; Elias, G.; Ostoich, M.T.; Teglia, O. 1993: Antipyretic effect of indomethacin vs aspirin in fever of tumor origin. Medicina 53(1): 35-38

Lyudyno, V.I.; Krasnova, I.N.; Smirnova, M.P.; Klimenko, V.M. 2001: Antipyretic effect of neuropeptide galanin in endotoxin-induced fever. Bulletin of Experimental Biology and Medicine 131(1): 60-63

Locham, K.K.; Sodhi, M.; Jindal, G. 2002: Antipyretic effect of nimesulide and paracetamol in children. Indian Pediatrics 39(11): 1074; Author Reply 1075

Leary, P.M.; Walker, K.G.; van der Meulen, W. 1997: Antipyretic effect of oral V. rectal paracetamol. South African Medical Journal 87(12): 1708

Duhamel, J.F.; Guillot, M.; Brouard, J.; Debosque, S.; Consten, L.; Dresco, I.; Perret, M.; Rezvani, Y. 1993: Antipyretic effect of tiaprofenic acid in children. Comparative study with paracetamol. Pediatrie 48(9): 655-659

Son, Y.-S.; Park, H.-J.; Kwon, O.-B.; Jung, S.-C.; Shin, H.-C.; Lim, S. 2002: Antipyretic effects of acupuncture on the lipopolysaccharide-induced fever and expression of interleukin-6 and interleukin-1 beta mRNAs in the hypothalamus of rats. Neuroscience Letters 319(1): 45-48

Wong, A.; Sibbald, A.; Ferrero, F.; Plager, M.; Santolaya, M.E.; Escobar, A.M.; Campos, S.; Barragán, S.; De León González, M.; Kesselring, G.L. 2001: Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: results of a multinational, randomized, modified double-blind study. Clinical Pediatrics 40(6): 313-324

Tréluyer, J.M.; Tonnelier, S.; d'Athis, P.; Leclerc, B.; Jolivet-Landreau, I.; Pons, G. 2001: Antipyretic efficacy of an initial 30-mg/kg loading dose of acetaminophen versus a 15-mg/kg maintenance dose. Pediatrics 108(4): E73

McMahon, F.G.; Vargas, R.; Hochstein, H.D. 2000: Antipyretic efficacy of aspirin or acetaminophen. Clinical Pharmacology and Therapeutics 67(1): 70-71

Conejo Menor, J.L.; Lallana Duplá, M.T. 2002: Antipyretic poisoning. Anales Espanoles de Pediatria 56(4): 318-323

Rajeshwari, K. 1997: Antipyretic therapy. Indian Pediatrics 34(5): 407-413

Sharma, J.C.; Ross, I.N. 1998: Antipyretic therapy in acute stroke. Lancet 352(9129): 740-741

McD Johnston, A. 2000: Antipyretic therapy is important following stroke. Archives of Internal Medicine 160(17): 2679-2680

Butterworth, R.F. 1998: Antipyretics and Reye's syndrome. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 21(4-5): 209-210

O'Connor, S. 2002: Antipyretics in the paediatric A&E setting: a review. Paediatric Nursing 14(3): 33-35

Dubey, N.K.; Jajoo, D.; Gupta, A.; Sharma, D. 1995: Antipyretics induced erythema multiforme. Indian Pediatrics 32(10): 1117-1119

Grieco, A.; Castellano, R.; Matera, A.; Ragazzoni, E.; Fontana, T.; Barone, C. 1994: Antipyrine Metabolism during Chemotherapy with 5-Fluorouracil Plus Folinic Acid in Patients with Liver Metastases from Primary Colorectal Cancer. American Journal of Therapeutics 1(4): 255-259

Konig, P.K.; Cantilena, L. 1994: Antipyrine as a model drug substance to assess oxidative metabolism. Archives of Internal Medicine 154(5): 590

Fabbri, A.; Bianchi, G.P.; Marchesini, G. 1997: Antipyrine clearance and response to interferon therapy in chronic hepatitis. Hepatology 25(2): 500-502

Radzikowska, E.; Gaździk, W.; Rowińska-Zakrzewska, E. 1993: Antipyrine metabolism in lung cancer patients. Pneumonologia i Alergologia Polska 61(9-10): 496-502

Radzikowska, E.; Gazdzik, W.; Rowińska-Zakrzewska, E. 1997: Antipyrine metabolism in lung cancer patients and their relatives. Roczniki Akademii Medycznej W Bialymstoku 42(Suppl 1): 297-308

Gichev, I.P.; Guseva, E.O.; Grek, O.P.; Sharapov, V.I. 1998: Antipyrine pharmacokinetics in rats with various resistance to hypoxia during cold stress. Biulleten' Eksperimental'noi Biologii i Meditsiny 126(11): 513-515

Nemchenko, N.S.; Vagner, V.K.; Erashev, O.N. 1998: Antipyrine test in evaluation of patient's hepatic failure in early postoperative period. Khirurgiia 1: 42-44

Berk, J.B. 1980: Antiquarian antisepsis. Contemporary Surgery 16(6): 62-63

Tillich, P. 1993: Antiquated concepts? Sin and grace. Krankenpflege Journal 31(3): 102-103

Cassidy, N. 1986: Antiquated hospital laundry is updated to cut down on maintenance, labor costs. Laundry News 12(11): 13

Bonnet-Cadilhac, C.; Moschion 1995: Antique and medieval representations of foetus in utero. Medicina Nei Secoli 7(2): 339-350

Anonymous 1982: Antique annual report: reminiscing through the files in Augusta. Profiles in hospital marketing 1982(5): 23

Fredgant, D. 1984: Antique pharmacy bottles: sources and pricing. Pharmacy in History 26(1): 46-49

Altchek, D.D. 2001: Antique, archaic and arcane dermatologic instrumentation and armamentarium. Mount Sinai Journal of Medicine new York 68(4-5): 309-320

Jackson, W.A. 1978: Antiques of Mander, Weaver and Co., Wolverhampton. Pharmaceutical Historian 8(3): 4-6

Gluckman, L. 1998: Antiques of the pharmacy in medical philately. Scalpel and Tongs: American Journal of Medical Philately 42: 95-97

Weinberg, F. 1995: Antiques of the pharmacy. Part 2: Offering relief when cure is impossible. Canadian Family Physician Medecin de Famille Canadien 41: 1754-1758

Stephenson, S. 1988: Antiques, apples and penny candies. Restaurants and Institutions 98(4): 94-95

Lawler, A. 2002: Antiquities. Global support grows for Afghan restoration. Science 295(5554): 419

Gould, J.S. 2002: Antiquity. American Journal of Orthopedics 31(2): 66

Altschuler, E.L.; Altshuler, E.L. 1999: Antiquity of Epstein-Barr virus, Sjögren's syndrome, and Hodgkin's disease--historical concordance and discordance. Journal of the National Cancer Institute 91(17): 1512-1513

Rothschild, B.M.; Sebes, J.I.; Rothschild, C. 1998: Antiquity of arthritis: spondyloarthropathy identified in the Paleocene of North America. off. Clinical and Experimental Rheumatology 16(5): 573-575

Eyben, E. 1972: Antiquity's view of puberty. Latomus 31: 677-697

Alleyne, J.; Papadopoulos, I.; Tilki, M. 1994: Antiracism within transcultural nurse education. British Journal of Nursing 3(12): 635-637

Foye, W.O.; Patarapanich, S. 1987: Antiradiation compounds: XXI. Metal ion complexation of bis(methylthio) and methylthio amino derivatives of 1-methylquinolinium-2-dithioacetic acids. Journal of Pharmaceutical Sciences 76(8): 650-653

Nizhenkovskaia, I.V.; Gubskiĭ, I.I.; Checkman, I.S.; Goriushko, A.G.; Gorchakova, N.A.; Sachenko, L.G. 1998: Antiradical activity and membranotropic action of cardio- and vasotropic compounds of varying chemical nature. Ukrainskii Biokhimicheskii Zhurnal 70(4): 51-58

Odin, A.P.; Aleksandrova, V.A.; Lebedev, A.V.; Topchiev, D.A.; Kotliarova, E.B.; Shevchenko, V.A. 1995: Antiradical activity of a diallyl series ternary copolymer in realizing an antimutagenic effect. Biulleten' Eksperimental'noi Biologii i Meditsiny 120(9): 265-267

Gubskiĭ, I.I.; Iurzhenko, N.N.; Shapoval, G.S.; Gromovaia, V.F.; Goriushko, A.G.; Averkov, A.I. 1998: Antiradical and antioxidant activity of certain membranotropic substances of synthetic and plant origin. Ukrainskii Biokhimicheskii Zhurnal 70(3): 128-134

Dunaev, V.V.; Belenichev, I.F.; Kovalenko, S.I.; Vashkin, I.N.; Avramenko, N.A.; Mazur, I.A.; Knysh, E.G.; Tishkin, V.S. 1996: Antiradical and antioxidant activity of derivatives of 1,2,4-triazole and quinazoline in cerebral ischemia. Ukrainskii Biokhimicheskii Zhurnal 68(1): 100-104

Gubskiĭ, I.I.; Goriushko, A.G.; Vistunova, I.E.; Kurapova, T.N.; Sachenko, L.G.; Danilenko, V.F. 1999: Antiradical and antioxidant properties of nonsteroidal anti-inflammatory agents--derivatives of pyridinecarboxylic acid. Ukrains'kyi Biokhimichnyi Zhurnal 71(5): 85-89

Lankin, V.Z.; Roginskiĭ, V.A.; Tikhaze, A.K.; Barsukova, T.K.; Ivanova, M.V.; Samuilov, I.D.; Kukharchuk, V.V. 1996: Antiradical and antioxidant properties of probucol and its structural analogs during oxidation of unsaturated phospholipids in native and artificial membranes. Doklady Akademii Nauk 351(4): 554-557

Agius, M.A.; Zhu, S.; Fairclough, R.H. 1998: Antirapsyn antibodies in chronic procainamide-associated myopathy (CPAM). Annals of the New York Academy of Sciences 841: 527-529

Schulz, U.; Schallenberg, U.B.; Kaiser, N. 2002: Antireflection coating design for plastic optics. Applied Optics 41(16): 3107-3110

Xu, Y.; Fan, W.H.; Li, Z.H.; Wu, D.; Sun, Y.H. 2003: Antireflective silica thin films with super water repellence via a solgel process. Applied Optics 42(1): 108-112

Scapinelli, R. 2000: Antireflux mechanisms in veins draining the upper territory of the vertebral column and spinal cord in man. Clinical Anatomy 13(6): 410-415

Kadirkamanathan, S.S.; Evans, D.F.; Gong, F.; Yazaki, E.; Scott, M.; Swain, C.P. 1996: Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointestinal Endoscopy 44(2): 133-143

Bálint, A.; Máté, M.; Barta, T.; Fazekas, T.; Solymosi, A.; Szabó, K. 2001: Antireflux procedures at our unit (1990-1999). Magyar Sebeszet 54(5): 283-286

Richter, J.E. 2001: Antireflux surgery and adenocarcinoma of the esophagus: let the truth be told. Gastroenterology 121(6): 1506-1508

Viljakka, M.; Saali, K.; Koskinen, M.; Karhumäki, L.; Kössi, J.; Luostarinen, M.; Teerenhovi, O.; Isolauri, J. 1999: Antireflux surgery enhances gastric emptying. Archives of Surgery 134(1): 18-21

Montes, C.G.; Brandalise, N.A.; Deliza, R.; Novais de Magalhães, A.F.; Ferraz, J.G. 1999: Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointestinal Endoscopy 50(2): 173-177

Hüttl, T.P.; Hohle, M.; Meyer, G.; Schildberg, F.W. 2002: Antireflux surgery in Germany. Results of a representative survey with analysis of 2,540 antireflux operations. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 73(5): 451-461

Sandbu, R.; Haglund, U.; Arvidsson, D.; Hallgren, T. 2000: Antireflux surgery in Sweden, 1987-1997: a decade of change. Scandinavian Journal of Gastroenterology 35(4): 345-348

Buderus, S.; Keller, K.M.; Lentze, M.J. 2001: Antireflux surgery in children suffering from reflux-associated respiratory disease?. Pediatric Pulmonology 31(4): 325-326

Ahrens, P.; Heller, K.; Beyer, P.; Zielen, S.; Kühn, C.; Hofmann, D.; Encke, A. 1999: Antireflux surgery in children suffering from reflux-associated respiratory diseases. Pediatric Pulmonology 28(2): 89-93

Fonkalsrud, E.W.; Bustorff-Silva, J.; Perez, C.A.; Quintero, R.; Martin, L.; Atkinson, J.B. 1999: Antireflux surgery in children under 3 months of age. Journal of Pediatric Surgery 34(4): 527-531

Hassall, E. 1998: Antireflux surgery in children: time for a harder look. Pediatrics 101(3 Part 1): 467-468

Watson, D.I.; Jamieson, G.G. 1998: Antireflux surgery in the laparoscopic era. British Journal of Surgery 85(9): 1173-1184

Watson, A. 1999: Antireflux surgery in the laparoscopic era. British Journal of Surgery 86(4): 571-572

DeMeester, T.R. 2000: Antireflux surgery in the management of Barrett's esophagus. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 4(2): 124-128

Braghetto, I.; Csendes, A.; Burdiles, P.; Korn, O. 2000: Antireflux surgery, highly selective vagotomy and duodenal switch procedure: post-operative evaluation in patients with complicated and non-complicated Barrett's esophagus. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 13(1): 12-17

Hinder, R.A.; Libbey, J.S.; Gorecki, P.; Bammer, T. 1999: Antireflux surgery. Indications, preoperative evaluation, and outcome. Gastroenterology Clinics of North America 28(4): 987

Rossetti, M. 1995: Antireflux surgery: from Nissen to mini-invasive technics. Minerva Chirurgica 50(9 Suppl): 104-108

Lozano de la Torre, M.J. 2000: Antiregurgitation formulas: are there any indications?. Anales Espanoles de Pediatria 53(5): 501

Starka; Broulik; Hampl; Nedvidkova; Hill 1996: Antirenotropic action of antiandrogens cyproterone acetate, casodex, flutamide and epitestosterone. Endocrine Regulations 30(2): 93-97

Dana; Eisenberg; Shnerb 1996: Antiresonance and localization in quantum dynamics. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 54(6): 5948-5963

Illarramendi; Balda; Fernández 1993: Antiresonances in the excitation and absorption spectra of Cr3+-doped fluoride glasses. Physical Review. B Condensed Matter 47(14): 8411-8417

Boykin; Pezeshki; Harris 1992: Antiresonances in the transmission of a simple two-state model. Physical Review. B Condensed Matter 46(19): 12769-12772

Lyanda-Geller; Leburton 1995: Antiresonant hopping conductance and negative magnetoresistance in quantum-box superlattices. Physical Review. B Condensed Matter 52(4): 2779-2783

Anonymous 1997: Antiresorptive therapy for bone. Fortschritte der Medizin. Supplement: die Kongressinformation für die Praxis 181: 1-11

Rastorguev, S.M.; Zavil'gel'skiĭ, G.B.; Churikov, N.A. 1998: Antirestriction activity of the transmissive plasmid R64 (IncI1) is determined by the arsR gene. Molekuliarnaia Biologiia 32(2): 297-300

Nolan, D.; John, M.; Mallal, S. 2001: Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis. Antiviral Therapy 6(3): 145-160

Nyazema, N.Z.; Khoza, S.; Landman, I.; Sibanda, E.; Gael, K. 2000: Antiretrovial (ARV) drug utilisation in Harare. Central African Journal of Medicine 46(4): 89-93

Hanna; D'Aquila 1999: Antiretroviral Drug Resistance in HIV-1. Current Infectious Disease Reports 1(3): 289-297

Schluger, N.W.; Burzynski, J. 2001: Tuberculosis and HIV infection: epidemiology, immunology, and treatment. HIV Clinical Trials 2(4): 356-365

Postic, B.; Bryan, C.S. 1996: Antiretroviral [correction of antiretrovial] therapy in mid-1996. Journal of the South Carolina Medical Association 92(9): 400-403

Naesens, L.; Balzarini, J.; Bischofberger, N.; De Clercq, E. 1996: Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine. Antimicrobial Agents and ChemoTherapy 40(1): 22-28

McMahon, D.; Lederman, M.; Haas, D.W.; Haubrich, R.; Stanford, J.; Cooney, E.; Horton, J.; Kelleher, D.; Ross, L.; Cutrell, A.; Lee, D.; Spreen, W.; Mellors, J.W. 2001: Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults. Antiviral Therapy 6(2): 105-114

Richman, D.D. 2001: Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor. Antiviral Therapy 6(2): 83-88

Riddler, S.A.; Anderson, R.E.; Mellors, J.W. 1995: Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T). Antiviral Research 27(3): 189-203

Wutoh, A.K.; Brown, C.M.; Kumoji, E.K.; Daftary, M.S.; Jones, T.; Barnes, N.A.; Powell, N.J. 2001: Antiretroviral adherence and use of alternative therapies among older HIV-infected adults. Journal of the National Medical Association 93(7-8): 243-250

Belzer, M.E.; Fuchs, D.N.; Luftman, G.S.; Tucker, D.J. 1999: Antiretroviral adherence issues among HIV-positive adolescents and young adults. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 25(5): 316-319

Zídek, Z.; Holý, A.; Franková, D. 1997: Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production. European Journal of Pharmacology 331(2-3): 245-252

Anonymous 2000: Antiretroviral agents. IARC monographs on the evaluation of carcinogenic risks to humans 76: 45-173

Loubeyre-Unique, C.; Gautier, A.; Vauzelle-Gardier, C.; Champart, A.M.; Bavoux, F. 2001: Antiretroviral agents and pregnancy: mitochondrial dysfunction and nucleoside analogs. Therapie 56(3): 261-266

Edmunds-Ogbuokiri, J. 2000: Antiretroviral agents should be dose adjusted in renal and hepatic impairment. HIV Clinician 12(2): 1-4

Harris, W.; Brown, G. 2001: Antiretroviral agents used in the treatment of HIV infections. Abnf Journal: Official Journal of the Association of Black Nursing Faculty in Higher Education Inc 12(3): 67-69

Chaudry, M.N.; Shepp, D.H. 1997: Antiretroviral agents. Current usage. Dermatologic Clinics 15(2): 319-329

Deeks, S.G. 1998: Antiretroviral agents: the next generation. Aids Clinical Care 10(5): 33-36; 39-40

Martin, M.; Serradji, N.; Dereuddre-Bosquet, N.; Bensaïd, O.; Fichet, G.; Lamouri, A.; Heymans, F.; Clayette, P.; Godfroid, J.J.; Dormont, D. 2000: Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601. Pathologie-Biologie 48(5): 513-519

König, N.; Poluch, S.; Estabel, J.; Durand, M.; Drian, M.J.; Exbrayat, J.M. 2001: Synaptic and non-synaptic AMPA receptors permeable to calcium. Japanese Journal of Pharmacology 86(1): 1-17

Saag, M.S.; Schooley, R.T. 1998: Antiretroviral chemotherapy. Current Clinical Topics in Infectious Diseases 18: 154-179

Thompson, C.A. 2001: Antiretroviral combination may put pregnant women at risk of fatal lactic acidosis. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 58(4): 291

Thiébaut, R.; Thiessard, F.; Merchadou, L.D.; Marimoutou, C.; Dabis, F. 1998: Antiretroviral combination therapy and HIV infection. Long term follow up of patients under triple therapy is necessary. Bmj 317(7162): 887-888

McMenamin, J.; Allardice, G.; Goldberg, D.; Parpia, T.; Raab, G.; Parpira, T. 1998: Antiretroviral combination therapy and HIV infection. Such treatment improved CD4 counts in Scottish patients. Bmj 317(7162): 887

Zorrilla, C.D. 2000: Antiretroviral combination therapy in HIV-1 infected women and men: are their responses different?. International Journal of Fertility and Women's Medicine 45(2): 195-199

Cooper, E.C. 1996: Antiretroviral combination treatment prolongs life in people with HIV/AIDS. Amfar Report 1996: 1-5

Josefson, D. 1997: Antiretroviral combinations do not eliminate HIV entirely. Bmj 315(7121): 1488

Anonymous 2001: Antiretroviral doses. Aids Policy and Law 16(18): 11

Vella, S. 2002: Antiretroviral drug resistance and HIV/AIDS in the developing world. Journal of HIV Therapy 7(3): 53-55

Hirsch, M.S.; Conway, B.; D'Aquila, R.T.; Johnson, V.A.; Brun-Vézinet, F.; Clotet, B.; Demeter, L.M.; Hammer, S.M.; Jacobsen, D.M.; Kuritzkes, D.R.; Loveday, C.; Mellors, J.W.; Vella, S.; Richman, D.D. 1998: Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. JAMA 279(24): 1984-1991

Torre, D.; Tambini, R. 2002: Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study. HIV Clinical Trials 3(1): 1-8

Richman, D.D. 1996: Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significance. Advances in Experimental Medicine and Biology 394: 383-395

Goldschmidt, R.H.; Moy, A. 1996: Antiretroviral drug treatment for HIV/AIDS. American Family Physician 54(2): 574-580; 587-588

Barini, O. 2001: Antiretroviral drugs. Revista da Associacao Medica Brasileira 47(3): 195-196

Rieger, A. 1998: Antiretroviral drugs 1998/1999. Wiener Medizinische Wochenschrift 148(23-24): 567-576

Bavoux, F.; Loubeyre-Unique, C.; Blanche, S. 2000: Antiretroviral drugs and pregnancy: apropos of an alert regarding mitochondrial pathology and nucleoside analogs. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 7 Suppl. 2: 407s-408s

Malkin, J.E. 2002: Antiretroviral drugs for the treatment and prevention of herpes infections in the year 2000. Pathologie-Biologie 50(8): 477-482

Walter, E. 1997: Therapy of hepatorenal syndrome. Praxis 86(4): 102-103

Kumarasamy, N.; Solomon, S.; Peters, E.; Amalraj, R.E.; Purnima, M.; Ravikumar, B.; Yepthomi, T.; Thyagarajan, S.P. 2000: Antiretroviral drugs in the treatment of people living with human immunodeficiency virus: experience in a south Indian tertiary referral centre. Journal of the Association of Physicians of India 48(4): 390-393

Anonymous 2000: Antiretroviral drugs not foolproof in preventing HIV infection via sex. AIDS weekly 2000: 2-3

Phillips, L. 1996: Antiretroviral drugs: new agents, new combinations line up against HIV. Hospital Technology Series 15(1): 1-3

Saag, M.S.; Sonnerborg, A.; Torres, R.A.; Lancaster, D.; Gazzard, B.G.; Schooley, R.T.; Romero, C.; Kelleher, D.; Spreen, W.; LaFon, S. 1998: Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team. Aids 12(16): F203-F209

Magnani, M.; Fraternale, A.; Casabianca, A.; Schiavano, G.F.; Chiarantini, L.; Palamara, A.T.; Ciriolo, M.R.; Rotilio, G.; Garaci, E. 1997: Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. Aids Research and Human Retroviruses 13(13): 1093-1099

Soloway, B.; Friedland, G. 2000: Antiretroviral failure: a biopsychosocial approach. Aids Clinical Care 12(3): 23-25; 30

Ostrop, N.J.; Gill, M.J. 2000: Antiretroviral medication adherence and persistence with respect to adherence tool usage. Aids Patient Care and Stds 14(7): 351-358

Frick, P.A.; Gal, P.; Lane, T.W.; Sewell, P.C. 1998: Antiretroviral medication compliance in patients with AIDS. Aids Patient Care and Stds 12(6): 463-470

Edelstein, H.; Wilson, M. 2001: Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital. Journal of Acquired Immune Deficiency Syndromes 28(5): 496

Kidd, M.R.; Anderson, J. 2002: Antiretroviral medications and HIV. Australian Family Physician 31(2): 135-139

Piscitelli, S.C. 1999: Antiretroviral pharmacology issues and management. Beta: Bulletin of Experimental Treatments for Aids: a Publication of the San Francisco Aids Foundation 12(4): 9-15

Lallemant, M.; Le Coeur, S.; Tarantola, D.; Mann, J.; Essex, M. 1994: Antiretroviral prevention of HIV perinatal transmission. Lancet 343(8910): 1429-1430

Sadovsky, R. 1998: Antiretroviral prophylaxis after recent sexual exposure to HIV. American Family Physician 58(2): 539-540

Castell Salvá, R.; Tomás Salvá, M.ía. 2002: Antiretroviral prophylaxis in a pregnant hospital worker. Medicina Clinica 119(2): 76-77

Sangraula, H.; Sharma, K.K.; Dwivedi, S. 2001: Antiretroviral protease inhibitor therapy leads to hyperglycaemia, hyperlipidaemia and lipodystrophy. National Medical Journal of India 14(6): 347-348

Anonymous 2000: Antiretroviral regimens: the more drugs, the better?. Aids Reader 10(3): 171-172

McIntosh, K. 1997: Antiretroviral resistance and HIV vertical transmission. Acta Paediatrica . Suppl 421: 29-32

Hammer, S.M.; Pedneault, L. 2000: Antiretroviral resistance testing comes of age. Antiviral Therapy 5(1): 23-26

Alcamí, J.; Rubio, R. 2001: Antiretroviral resistance testing. a necessary element in the follow-up of the HIV-infected patient. Enfermedades Infecciosas y Microbiologia Clinica 19(Monografico): 1-2

Nunes, D.; Piliero, P.J. 2000: Antiretroviral rounds. a co-infection treatment dilemma. Aids Clinical Care 12(7): 58-59

Henderson, D.; Caliendo, A.M. 2000: Antiretroviral rounds. a red herring?. Aids Clinical Care 12(8): 66-67

Henry, K.; Jenny-Avital, E. 2002: Antiretroviral rounds. A very discordant response. Aids Clinical Care 14(1): 4-5 8

Piliero, P.J.; Jenny-Avital, E.R. 2002: Antiretroviral rounds. Failure to achieve full virologic suppression. Aids Clinical Care 14(11): 100-101

Neu, N. 2000: Antiretroviral rounds. one patient, with another on the way. Aids Clinical Care 12(5): 42-43

Sax, P.E.; Piliero, P.J. 2000: Antiretroviral rounds. Personal and public consequences. Aids Clinical Care 12(1): 4-5

Henry, K.; Hicks, C. 2000: Antiretroviral rounds. Reason to be worried. Aids Clinical Care 12(10): 82-83

Piliero, P.J.; Jenny-Avital, E. 2000: Antiretroviral rounds. time for a holiday. Aids Clinical Care 12(3): 26-27

Bartlett, J.G.; del Rio, C. 2001: Antiretroviral rounds. when success is a pain. Aids Clinical Care 13(8): 74-75

Hicks, C.; Feinberg, J. 2002: Antiretroviral rounds. "Doc, I've been making mistakes". Aids Clinical Care 14(12): 108-109

Glesby, M.J. 2000: Antiretroviral switching studies--the jury is still out. Aids Reader 10(8): 482-483

Owen, W.F. 1998: Antiretroviral therapies. Clinics in Podiatric Medicine and Surgery 15(2): 227-239

Lorenzi, P.; Spicher, V.M.; Laubereau, B.; Hirschel, B.; Kind, C.; Rudin, C.; Irion, O.; Kaiser, L. 1998: Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. Aids 12(18): F241-F247

Enzensberger, W.; von Giesen, H.J. 1999: Antiretroviral therapy (ART) from a neurological point of view. German Neuro-AIDS study group (DNAA). European Journal of Medical Research 4(11): 456-462

Beck, J.M. 1996: Antiretroviral therapy 1996. Journal of the Arkansas Medical Society 92(10): 499-500

Zangerle, R. 1998: Antiretroviral therapy 1998/1999: what is our current status?--Avoiding therapy failure instead of expecting it. Wiener Medizinische Wochenschrift 148(23-24): 527-529

Jablonowski, H. 1999: Antiretroviral therapy 1999/2000. Der Internist 40(10): 1104-1118

Jablonowski, H. 2001: Antiretroviral therapy 2001. Basic principles and current status. MMW Fortschritte der Medizin 143(Suppl 1): 4-12

Zambrano, C.H. 2002: Antiretroviral therapy 2002. Positively Aware: the Monthly Journal of the Test Positive Aware Network 13(1): 27

Lange, J.M.; Richman, D.D. 1996: Antiretroviral therapy and clinical trials: what now?. Antiviral Therapy 1(2): 69-70

Cohen, K.; Andrews, S.; Maartens, G. 2001: Antiretroviral therapy and drug interactions. South African Medical Journal 91(10): 816-819

Carcelain, G.; Li, T.S.; Renaud, M.; Blanc, C.; Tubiana, R.; Calvez, V.; Leibowitch, J.; Debré, P.; Agut, H.; Katlama, C.; Autran, B. 1999: Antiretroviral therapy and immune reconstitution. Journal de la Societe de Biologie 193(1): 5-10

De Luca, A.; Antinori, A.; Ortona, L. 1998: Antiretroviral therapy and improving AIDS survival. JAMA 279(23): 1874-1875

Denver, R.J. 1998: The molecular basis of thyroid hormone-dependent central nervous system remodeling during amphibian metamorphosis. Comparative Biochemistry and Physiology. Part C Pharmacology Toxicology and Endocrinology 119(3): 219-228

Caselli, D.; Maccabruni, A.; Furione, M. 1993: Congenital double infection by human immunodeficiency virus and human cytomegalovirus. Pediatric Infectious Disease Journal 12(6): 533-535

Teglas, J.P.; Mayaux, M.J.; Blanche, S. 2000: Antiretroviral therapy and mortality among children with perinatal HIV infection. JAMA 284(22): 2871-2872

Monpoux, F.; Bongain, A.; Bérard, E.; Gillet, J.Y. 1999: Antiretroviral therapy and prevention of maternal-fetal transmission of HIV-1. Current and future strategies. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 6(5): 556-565

John, M.; Nolan, D.; Mallal, S. 2001: Antiretroviral therapy and the lipodystrophy syndrome. Antiviral Therapy 6(1): 9-20

Ncayiyana, D.J. 2001: Antiretroviral therapy cannot be South Africa's first priority. Cmaj: Canadian Medical Association Journal 164(13): 1857-1858

Anonymous 1999: Antiretroviral therapy does not prevent HIV related non-Hodgkin's lymphoma. Bmj 319(7201): e

Kovelesky, R.A.; Minor, J.R. 1994: Antiretroviral therapy during pregnancy. American Journal of Hospital Pharmacy 51(17): 2187-2189

Thorne, C.; Fiore, S.; Rudin, C. 2003: Antiretroviral therapy during pregnancy and the risk of an adverse outcome. New England Journal of Medicine 348(5): 471

Dattel, B.J. 1997: Antiretroviral therapy during pregnancy. Beyond AZT (ZDV). Obstetrics and Gynecology Clinics of North America 24(3): 645-657

Carpenter, C.C.; Fischl, M.A.; Hammer, S.M.; Hirsch, M.S.; Jacobsen, D.M.; Katzenstein, D.A.; Montaner, J.S.; Richman, D.D.; Sáag, M.S.; Schooley, R.T.; Thompson, M.A.; Vella, S.; Yeni, P.G.; Volberding, P.A. 1996: Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 276(2): 146-154

Henry, K.; Stiffman, M.; Feldman, J. 1997: Antiretroviral therapy for HIV infection. Heartening successes mixed with continuing challenges. Postgraduate Medicine 102(4): 100-7 111-3 119-20

Bright, D.C. 1999: Antiretroviral therapy for HIV infection: a review of current medications and therapies. Journal of the American Optometric Association 70(6): 355-383

Smith, N.A.; Shaw, T.; Berry, N.; Vella, C.; Okorafor, L.; Taylor, D.; Ainsworth, J.; Choudhury, A.; Daniels, R.S.; El-Gadi, S.; Fakoya, A.; Moyle, G.; Oxford, J.; Tedder, R.; O'Shea, S.; de Ruiter, A.; Breuer, J. 2001: Antiretroviral therapy for HIV-2 infected patients. Journal of Infection 42(2): 126-133

Burkle, W.S. 2002: Antiretroviral therapy for HIV: drug resistance and sequencing. Journal of the Association of Nurses in Aids Care: Janac 13(1): 76-80

Sande, M.A.; Carpenter, C.C.; Cobbs, C.G.; Holmes, K.K.; Sanford, J.P. 1993: Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. JAMA 270(21): 2583-2589

Anonymous 1995: Antiretroviral therapy for adults and children. Aids Institute Newsletter. new York . Aids Institute 1995: 1-19

Ress, B.C. 1998: Antiretroviral therapy for human immunodeficiency virus disease: implications for critical care nursing. Critical Care Nurse 18(6): 54-62

Katzenstein, D.A. 1997: Antiretroviral therapy for human immunodeficiency virus infection in 1997. Western Journal of Medicine 166(5): 319-325

Terriff, C.M.; Synoground, G. 1998: Antiretroviral therapy for pediatric and adolescent HIV. Journal of School Nursing: the Official Publication of the National Association of School Nurses 14(2): 36-46

Luber, A.D.; Dong, B.J. 2000: Antiretroviral therapy for pregnant HIV-infected women. Annals of Internal Medicine 132(6): 509

Montaner, J.S.; Mellors, J.W. 2001: Antiretroviral therapy for previously treated patients. New England Journal of Medicine 345(6): 452-455

Jablonowski, H. 1996: Antiretroviral therapy in HIV infection. Medizinische Monatsschrift für Pharmazeuten 19(7): 196-205

Manfredi, R.; Fiacchi, P.; Riolo, U.; Chiodo, F. 2000: Antiretroviral therapy in HIV infection. Effects of the introduction of new drugs on health care expenditures, 1994-1999. Recenti Progressi in Medicina 91(9): 425-429

Lancaster, D.J.; Lancaster, L.L. 1994: Antiretroviral therapy in HIV-infected adults. Which regimens are recommended?. Postgraduate Medicine 95(1): 47-50 53-5

Shannon, M. 2002: Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges. Journal of Perinatal and Neonatal Nursing 16(2): 1-25

Laurence, J. 2000: Antiretroviral therapy in HIV/AIDS: update from San Francisco. Aids Reader 10(3): 133-134

Bekker, L-Gail.; Wood, R. 2002: Antiretroviral therapy in South Africa--can we do it?. South African Medical Journal 92(3): 191-193

Wise, B. 1996: Antiretroviral therapy in adults. Journal of the American Academy of Nurse Practitioners 8(7): 329-341

Feiterna-Sperling, C. 1999: Antiretroviral therapy in childhood. Zentralblatt für Gynakologie 121(1): 35-36

Jakob-Sölder, B. 1998: Antiretroviral therapy in children. Wiener Medizinische Wochenschrift 148(23-24): 539-546

Cotton, M.F. 2000: Antiretroviral therapy in children--increased benefit from increased complexity. South African Medical Journal 90(10): 985-988

Arya, S.C. 1998: Antiretroviral therapy in countries with low health expenditure. Lancet 351(9113): 1433-1434

Spooner, K.M. 1998: Antiretroviral therapy in human immunodeficiency virus-infected individuals. Advances in Internal Medicine 43: 373-402

Corti, M.E. 1998: Antiretroviral therapy in patients infected with HIV-1. Medicina 58(Suppl 1): 49-56

Schutten, M.; van der Ende, M.E.; Osterhaus, A.D. 2000: Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2. New England Journal of Medicine 342(23): 1758-1760

Trotta, M.; Meli, M.; Ginelli, R.; Sbaragli, S.; Leoncini, F. 2001: Antiretroviral therapy in pregnant women of Florence. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 5(4): 230-231

Niemiec, K.T.; Horban, A.; Chazan, B.; Firlag-Burkacka, E. 1998: Antiretroviral therapy in pregnant women with HIV. Ginekologia Polska 69(11): 820-826

Corey, L.; Berrey, M.M. 1999: Antiretroviral therapy in primary HIV. Advances in Experimental Medicine and Biology 458: 223-227

Friedland, G. 1995: Antiretroviral therapy in the future. Revista da Sociedade Brasileira de Medicina Tropical 28(Suppl 2): 53-63; Discussion: 63-66

Augenbraun, M.; Minkoff, H.L. 1997: Antiretroviral therapy in the pregnant woman. Obstetrics and Gynecology Clinics of North America 24(4): 833-854

Tashima, K.T.; Flanigan, T.P. 2000: Antiretroviral therapy in the year 2000. Infectious Disease Clinics of North America 14(4): 827-849

Lohman, J.J.; Reichert, L.J.; Degen, L.P. 1999: Antiretroviral therapy increases serum concentrations of amiodarone. Annals of PharmacoTherapy 33(5): 645-646

Mbewu, A. 2001: Antiretroviral therapy is only part of it. Bulletin of the World Health Organization 79(12): 1152

Allouch, H. 1998: Antiretroviral therapy of HIV infections. New recommendations by the International AIDS Society. Presse Medicale 27(34): 1739-1741

Rockstroh, J.K. 2000: Antiretroviral therapy of HIV-infections. Pharmazie in Unserer Zeit 29(5): 284-296